<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="apha70057" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Acta Physiol (Oxf)</journal-id><journal-id journal-id-type="iso-abbrev">Acta Physiol (Oxf)</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1748-1716</journal-id><journal-id journal-id-type="publisher-id">APHA</journal-id><journal-title-group><journal-title>Acta Physiologica (Oxford, England)</journal-title></journal-title-group><issn pub-type="ppub">1748-1708</issn><issn pub-type="epub">1748-1716</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40411205</article-id><article-id pub-id-type="pmc">PMC12102643</article-id><article-id pub-id-type="doi">10.1111/apha.70057</article-id><article-id pub-id-type="publisher-id">APHA70057</article-id><article-id pub-id-type="other">APH-2024-12-0747.R1</article-id><article-categories><subj-group subj-group-type="overline"><subject>Research Paper</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Paper</subject></subj-group></article-categories><title-group><article-title>Neutrophil Function in Patients With Chronic Kidney Disease: A Systematic Review and Meta&#x02010;Analysis</article-title></title-group><contrib-group><contrib id="apha70057-cr-0001" contrib-type="author"><name><surname>Lauxen</surname><given-names>Jane Sophie</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0003-4358-9062</contrib-id><xref rid="apha70057-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="apha70057-cr-0002" contrib-type="author"><name><surname>Vondenhoff</surname><given-names>Sonja</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0003-6351-2441</contrib-id><xref rid="apha70057-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="apha70057-cr-0003" contrib-type="author"><name><surname>Junho</surname><given-names>Carolina Victoria Cruz</given-names></name><xref rid="apha70057-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="apha70057-cr-0004" contrib-type="author"><name><surname>Martin</surname><given-names>Philipp</given-names></name><xref rid="apha70057-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="apha70057-cr-0005" contrib-type="author"><name><surname>Fleig</surname><given-names>Susanne</given-names></name><xref rid="apha70057-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="apha70057-cr-0006" contrib-type="author"><name><surname>Sch&#x000fc;tt</surname><given-names>Katharina</given-names></name><xref rid="apha70057-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="apha70057-cr-0007" contrib-type="author"><name><surname>Schulze&#x02010;Sp&#x000e4;te</surname><given-names>Ulrike</given-names></name><xref rid="apha70057-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="apha70057-cr-0008" contrib-type="author"><name><surname>Soehnlein</surname><given-names>Oliver</given-names></name><xref rid="apha70057-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="apha70057-cr-0009" contrib-type="author"><name><surname>Prates&#x02010;Roma</surname><given-names>Leticia</given-names></name><xref rid="apha70057-aff-0006" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib id="apha70057-cr-0010" contrib-type="author"><name><surname>D&#x000f6;ring</surname><given-names>Yvonne</given-names></name><xref rid="apha70057-aff-0007" ref-type="aff">
<sup>7</sup>
</xref><xref rid="apha70057-aff-0008" ref-type="aff">
<sup>8</sup>
</xref><xref rid="apha70057-aff-0009" ref-type="aff">
<sup>9</sup>
</xref><xref rid="apha70057-aff-0010" ref-type="aff">
<sup>10</sup>
</xref></contrib><contrib id="apha70057-cr-0011" contrib-type="author"><name><surname>Baaten</surname><given-names>Constance C. F. M. J.</given-names></name><xref rid="apha70057-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="apha70057-aff-0011" ref-type="aff">
<sup>11</sup>
</xref><xref rid="apha70057-aff-0012" ref-type="aff">
<sup>12</sup>
</xref></contrib><contrib id="apha70057-cr-0012" contrib-type="author" corresp="yes"><name><surname>Noels</surname><given-names>Heidi</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3053-6984</contrib-id><xref rid="apha70057-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="apha70057-aff-0011" ref-type="aff">
<sup>11</sup>
</xref><xref rid="apha70057-aff-0012" ref-type="aff">
<sup>12</sup>
</xref><address><email>hnoels@ukaachen.de</email></address></contrib></contrib-group><aff id="apha70057-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Institute for Molecular Cardiovascular Research (IMCAR)</named-content>
<institution>RWTH Aachen University</institution>
<city>Aachen</city>
<country country="DE">Germany</country>
</aff><aff id="apha70057-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Nephrology and Clinical Immunology</named-content>
<institution>RWTH Aachen University</institution>
<city>Aachen</city>
<country country="DE">Germany</country>
</aff><aff id="apha70057-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Internal Medicine I&#x02014;Cardiology, Angiology and Internal Intensive Care Medicine</named-content>
<institution>RWTH Aachen University Hospital</institution>
<city>Aachen</city>
<country country="DE">Germany</country>
</aff><aff id="apha70057-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Section of Geriodontics, Department of Conservative Dentistry and Periodontics</named-content>
<institution>University Hospital Jena</institution>
<city>Jena</city>
<country country="DE">Germany</country>
</aff><aff id="apha70057-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Institute of Experimental Pathology (ExPat)</named-content>
<institution>Center for Molecular Biology of Inflammation (ZMBE), University Hospital M&#x000fc;nster, University of M&#x000fc;nster</institution>
<city>M&#x000fc;nster</city>
<country country="DE">Germany</country>
</aff><aff id="apha70057-aff-0006">
<label>
<sup>6</sup>
</label>
<named-content content-type="organisation-division">Biophysics, Center for Integrative Physiology and Molecular Medicine (CIPMM), Center for Human and Molecular Medicine (ZHMB), Center for Gender&#x02010;Specific Biology and Medicine (CGBM), Faculty of Medicine</named-content>
<institution>Saarland University</institution>
<city>Homburg</city>
<country country="DE">Germany</country>
</aff><aff id="apha70057-aff-0007">
<label>
<sup>7</sup>
</label>
<named-content content-type="organisation-division">Division of Angiology, Swiss Cardiovascular Center, Inselspital, Bern University Hospital</named-content>
<institution>University of Bern</institution>
<city>Bern</city>
<country country="CH">Switzerland</country>
</aff><aff id="apha70057-aff-0008">
<label>
<sup>8</sup>
</label>
<named-content content-type="organisation-division">Department for BioMedical Research (DBMR)</named-content>
<institution>University of Bern</institution>
<city>Bern</city>
<country country="CH">Switzerland</country>
</aff><aff id="apha70057-aff-0009">
<label>
<sup>9</sup>
</label>
<institution>DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance</institution>
<city>Munich</city>
<country country="DE">Germany</country>
</aff><aff id="apha70057-aff-0010">
<label>
<sup>10</sup>
</label>
<institution>Institute for Cardiovascular Prevention (IPEK), Ludwig&#x02010;Maximilians&#x02010;University Munich (LMU)</institution>
<city>Munich</city>
<country country="DE">Germany</country>
</aff><aff id="apha70057-aff-0011">
<label>
<sup>11</sup>
</label>
<named-content content-type="organisation-division">Department of Biochemistry, CARIM, Cardiovascular Research Institute Maastricht</named-content>
<institution>Maastricht University</institution>
<city>Maastricht</city>
<country country="NL">the Netherlands</country>
</aff><aff id="apha70057-aff-0012">
<label>
<sup>12</sup>
</label>
<named-content content-type="organisation-division">Aachen&#x02010;Maastricht Institute for Cardiorenal Disease (AMICARE)</named-content>
<institution>University Hospital RWTH Aachen</institution>
<city>Aachen</city>
<country country="DE">Germany</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold>
<break/>
Heidi Noels (<email>hnoels@ukaachen.de</email>)<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>24</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>6</month><year>2025</year></pub-date><volume>241</volume><issue seq="160">6</issue><issue-id pub-id-type="doi">10.1111/apha.v241.6</issue-id><elocation-id>e70057</elocation-id><history>
<date date-type="rev-recd"><day>01</day><month>4</month><year>2025</year></date>
<date date-type="received"><day>08</day><month>12</month><year>2024</year></date>
<date date-type="accepted"><day>03</day><month>5</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">Acta Physiologica</italic> published by John Wiley &#x00026; Sons Ltd on behalf of Scandinavian Physiological Society.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:APHA-241-e70057.pdf"/><abstract><title>ABSTRACT</title><sec id="apha70057-sec-0001"><title>Background</title><p>Patients with chronic kidney disease (CKD) are at increased cardiovascular risk. Since neutrophils play a central role in atherosclerosis and cardiovascular disease, this study analyzed neutrophil function in CKD patients.</p></sec><sec id="apha70057-sec-0002"><title>Methods</title><p>A systematic review of neutrophil function in CKD patients compared to controls was performed according to PRISMA guidelines by searching PubMed and the Web of Science. A meta&#x02010;analysis summarized the production of reactive oxygen species (ROS) in CKD patients on dialysis in Forest plots. Influencer outlier analyses evaluated risk of bias.</p></sec><sec id="apha70057-sec-0003"><title>Results</title><p>Overall, 92 studies were included, of which 18 in the meta&#x02010;analysis. Although study heterogeneity was high, the systematic review identified primarily reduced phagocytosis capacity but increased neutrophil degranulation and basal ROS production in neutrophils from CKD patients on hemodialysis compared to controls. Phagocytosis and basal ROS production were mainly unaltered in non&#x02010;dialysis dependent CKD patients and CKD patients on peritoneal dialysis. The meta&#x02010;analysis confirmed increased ROS generation in basal conditions predominantly in CKD patients on hemodialysis (Hedges <italic toggle="no">g</italic>&#x02009;=&#x02009;1.20, 95% CI: [0.32; 2.09]), with an insufficient study number for a clear comparison to CKD patients on peritoneal dialysis. However, upon neutrophil stimulation with sterile inflammatory triggers, ROS production was also increased in neutrophils from patients on peritoneal dialysis (Hedges <italic toggle="no">g</italic>&#x02009;=&#x02009;0.89, 95% CI: [0.34; 1.43]).</p></sec><sec id="apha70057-sec-0004"><title>Conclusion</title><p>Increased degranulation and basal ROS formation were observed in neutrophils of CKD patients on hemodialysis, which could contribute to their increased cardiovascular risk. Future studies should compare neutrophil activity in patients of different CKD stages and comorbidities also in relation to cardiovascular outcomes.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="apha70057-kwd-0001">chronic kidney disease</kwd><kwd id="apha70057-kwd-0002">neutrophils</kwd><kwd id="apha70057-kwd-0003">reactive oxygen species</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>Interdisciplinary Centre for Clinical Research, Faculty of Medicine, RWTH Aachen University</funding-source></award-group><award-group id="funding-0002"><funding-source>Dutch Heart Foundation</funding-source></award-group><award-group id="funding-0003"><funding-source><institution-wrap><institution>Alexander von Humboldt&#x02010;Stiftung
</institution><institution-id institution-id-type="doi">10.13039/100005156</institution-id></institution-wrap></funding-source></award-group><award-group id="funding-0004"><funding-source><institution-wrap><institution>RWTH Aachen, Start&#x02010;up Funding
</institution><institution-id institution-id-type="doi">10.13039/501100007210</institution-id></institution-wrap></funding-source></award-group><award-group id="funding-0005"><funding-source><institution-wrap><institution>Deutsche Stiftung f&#x000fc;r Herzforschung
</institution><institution-id institution-id-type="doi">10.13039/501100005970</institution-id></institution-wrap></funding-source></award-group><award-group id="funding-0006"><funding-source><institution-wrap><institution>European Foundation for the Study of Diabetes
</institution><institution-id institution-id-type="doi">10.13039/501100001648</institution-id></institution-wrap></funding-source></award-group><award-group id="funding-0007"><funding-source><institution-wrap><institution>Deutsche Forschungsgemeinschaft
</institution><institution-id institution-id-type="doi">10.13039/501100001659</institution-id></institution-wrap></funding-source></award-group><award-group id="funding-0008"><funding-source><institution-wrap><institution>Deutsches Zentrum f&#x000fc;r Herz&#x02010;Kreislaufforschung
</institution><institution-id institution-id-type="doi">10.13039/100010447</institution-id></institution-wrap></funding-source></award-group></funding-group><counts><fig-count count="4"/><table-count count="2"/><page-count count="14"/><word-count count="9100"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>June 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.6 mode:remove_FC converted:24.05.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="apha70057-ntgp-0001"><fn fn-type="funding" id="apha70057-note-0001"><p>
<bold>Funding:</bold> This work was supported by the German Research Foundation (DFG) Project&#x02010;ID 322900939&#x02014;SFB/TRR219 [M05 to H.N., C07 to K.S., C09 to L.P.&#x02010;R.], Project&#x02010;ID 403224013&#x02014;SFB 1382 [A04 to H.N.], the DZHK (German Centre for Cardiovascular Research) [B23Ex to H.N. and Y.D.], the Alexander von Humboldt Foundation [postdoctoral fellowship to C.V.C.J.], the RWTH Aachen, Start&#x02010;up Funding [StUpPD_436&#x02013;23 to C.V.C.J.], the Interdisciplinary Centre for Clinical Research, Faculty of Medicine, RWTH Aachen University [PTD 1&#x02010;12 to H.N.], and the Dutch Heart Foundation&#x000a0;[2020T020 to C.C.F.M.J.B.] as well as the Deutsche Stiftung f&#x000fc;r Herzforschung [F/61/23 to C.B.]. O.S. receives funding from the DFG (TRR332 projects A2 &#x00026; Z1, CRC1123 project A6, CRU342 project P1, SO876/16&#x02010;1). Also, this work supported by EFSD on &#x0201c;Multi&#x02010;System Challenges in Diabetes,&#x000a0;Obesity and Cardiometabolic Disease&#x0201d; 2024 (to H.N.). The funding sources were not involved in the conduct of research and/or data interpretation.</p></fn></fn-group></notes></front><body id="apha70057-body-0001"><def-list list-content="abbreviations" id="apha70057-dl-0001"><title>Abbreviations</title><def-item><term id="apha70057-li-0001">CI</term><def id="apha70057-li-0002"><p>confidence interval</p></def></def-item><def-item><term id="apha70057-li-0003">CKD</term><def id="apha70057-li-0004"><p>chronic kidney disease</p></def></def-item><def-item><term id="apha70057-li-0005">CVD</term><def id="apha70057-li-0006"><p>cardiovascular disease</p></def></def-item><def-item><term id="apha70057-li-0007">fMLP</term><def id="apha70057-li-0008"><p>N&#x02010;formylmethionyl&#x02010;leucyl&#x02010;phenylalanine (officially called fMLF)</p></def></def-item><def-item><term id="apha70057-li-0009">HD</term><def id="apha70057-li-0010"><p>hemodialysis</p></def></def-item><def-item><term id="apha70057-li-0011">MPO</term><def id="apha70057-li-0012"><p>myeloperoxidase</p></def></def-item><def-item><term id="apha70057-li-0013">NETs</term><def id="apha70057-li-0014"><p>neutrophil extracellular traps</p></def></def-item><def-item><term id="apha70057-li-0015">NOX</term><def id="apha70057-li-0016"><p>NADPH&#x02010;oxidase</p></def></def-item><def-item><term id="apha70057-li-0017">PD</term><def id="apha70057-li-0018"><p>peritoneal dialysis</p></def></def-item><def-item><term id="apha70057-li-0019">PMA</term><def id="apha70057-li-0020"><p>Phorbol 12&#x02010;myristate 13&#x02010;acetate</p></def></def-item><def-item><term id="apha70057-li-0021">ROS</term><def id="apha70057-li-0022"><p>reactive oxygen species</p></def></def-item><def-item><term id="apha70057-li-0023">TNF</term><def id="apha70057-li-0024"><p>tumor necrosis factor</p></def></def-item></def-list><sec id="apha70057-sec-0005"><label>1</label><title>Introduction</title><p>Chronic kidney disease (CKD) is characterized by kidney damage or a reduced kidney filtration function for more than 3&#x02009;months and has a substantial impact on health and survival outcomes [<xref rid="apha70057-bib-0001" ref-type="bibr">1</xref>]. It has a global prevalence of ~13.4% [<xref rid="apha70057-bib-0002" ref-type="bibr">2</xref>] and a high socio&#x02010;economic and environmental burden. CKD is a progressive disease and is classified in CKD stages 1&#x02013;5 based on the remaining glomerular filtration rate (GFR): patients can present with a normal to mild kidney dysfunction (CKD1&#x02010;2), a mild&#x02013;moderate or moderate&#x02013;severe kidney dysfunction (CKD3a/b), a severe kidney impairment (CKD4) or complete kidney failure (CKD5) [<xref rid="apha70057-bib-0003" ref-type="bibr">3</xref>]. In this last stage, patients require kidney replacement therapy such as dialysis (hemodialysis (HD) or peritoneal dialysis (PD)) and kidney transplantation for survival. However, even with these interventions, life expectancy remains shortened, particularly due to an increase in cardiovascular risk that starts already in the early stages of CKD and grows exponentially with the progression of kidney dysfunction [<xref rid="apha70057-bib-0004" ref-type="bibr">4</xref>].</p><p>Overall, CKD patients show a chronic low&#x02010;grade inflammation and innate immune activation [<xref rid="apha70057-bib-0005" ref-type="bibr">5</xref>], leading to progressive atherosclerosis [<xref rid="apha70057-bib-0006" ref-type="bibr">6</xref>, <xref rid="apha70057-bib-0007" ref-type="bibr">7</xref>] and an increased risk of cardiovascular and thrombotic complications [<xref rid="apha70057-bib-0004" ref-type="bibr">4</xref>, <xref rid="apha70057-bib-0006" ref-type="bibr">6</xref>, <xref rid="apha70057-bib-0008" ref-type="bibr">8</xref>, <xref rid="apha70057-bib-0009" ref-type="bibr">9</xref>]. Neutrophil granulocytes are the most abundant leukocytes in the blood and play an important role in cardiovascular disease (CVD) including atherosclerosis and thrombotic risk through the production of reactive oxygen species (ROS), the release of pro&#x02010;inflammatory molecules (e.g., neutrophil elastase and myeloperoxidase) and the formation of neutrophil extracellular traps (NETs) [<xref rid="apha70057-bib-0010" ref-type="bibr">10</xref>, <xref rid="apha70057-bib-0011" ref-type="bibr">11</xref>]. Increased neutrophil numbers [<xref rid="apha70057-bib-0012" ref-type="bibr">12</xref>, <xref rid="apha70057-bib-0013" ref-type="bibr">13</xref>] and alterations in neutrophil activation responses have been reported [<xref rid="apha70057-bib-0010" ref-type="bibr">10</xref>] in CKD, though with a wide variety in readouts. Therefore, we executed a systematic review on the effects of CKD on neutrophil phenotype and function. We also performed a meta&#x02010;analysis of neutrophil ROS production in CKD patients, since this was the most frequently studied readout of neutrophil responses in CKD and because of the critical role of ROS production in the context of CVD.</p></sec><sec sec-type="methods" id="apha70057-sec-0006"><label>2</label><title>Methods</title><p>This study was performed according to the Preferred Reporting Items for Systematic reviews and Meta&#x02010;Analyses (PRISMA) guidelines.</p><sec id="apha70057-sec-0007"><label>2.1</label><title>Systematic Review: Search Strategy, Eligibility Criteria and Data Extraction</title><p>PubMed and the Web of Science were searched for studies describing the effects of CKD on human neutrophil function published 01/1990&#x02013;09/2023, with Table&#x000a0;<xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S1</xref> providing full details on the systematic search strategy as well as in&#x02010; and exclusion criteria for both the systematic review and the meta&#x02010;analysis. In short, studies were considered eligible when the phenotype or function of peripheral blood neutrophils was assessed in CKD patients in comparison to healthy volunteers, with readouts including&#x02014;but not restricted to&#x02014;surface activation marker expression, degranulation, ROS production, NET formation, apoptosis, and phagocytosis, and this both in basal as well as stimulated conditions (Figure&#x000a0;<xref rid="apha70057-fig-0001" ref-type="fig">1</xref>). Studies were selected independently by two reviewers (J.S.L., P.M.) based on the predefined eligibility criteria (Table&#x000a0;<xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S1</xref>, Figure&#x000a0;<xref rid="apha70057-fig-0001" ref-type="fig">1</xref>), with eventual disagreements resolved by consulting a third reviewer (H.N.). Additional relevant publications were identified by crosschecking the reference lists of the retrieved studies and relevant reviews (J.S.L., H.N.).</p><fig position="float" fig-type="FIGURE" id="apha70057-fig-0001"><label>FIGURE 1</label><caption><p>Flow chart of study selection for systematic review and meta&#x02010;analysis of neutrophil function in CKD. CKD, chronic kidney disease; NET, neutrophil extracellular traps; ROS, reactive oxygen species.</p></caption><graphic xlink:href="APHA-241-e70057-g001" position="anchor" id="jats-graphic-1"/></fig><p>Data extracted from full&#x02010;text articles include patient characteristics and study size, as well as findings on neutrophil apoptosis, activation markers, phagocytic activity, ROS production, degranulation, and NET release (Tables&#x000a0;<xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S2&#x02013;S8</xref>, J.S.L., double&#x02010;checked by C.V.C.J.).</p></sec><sec id="apha70057-sec-0008"><label>2.2</label><title>Meta&#x02010;Analysis: Data Extraction and Quality Assessment</title><p>Since ROS production (i) was the most studied readout, (ii) contributes to CVD pathophysiology, and (iii) showed a high data variability in the systematic review, a meta&#x02010;analysis with different subgroup analyses was performed for neutrophil ROS production in CKD. The meta&#x02010;analysis could only be performed in CKD patients on dialysis compared to healthy controls, given the insufficient number of datasets for non&#x02010;dialysis dependent CKD patients. Studies measured intracellular ROS (by flow cytometric analysis of 2&#x02032;,7&#x02032;&#x02010;dichlorodihydrofluorescein diacetate (DCFH&#x02010;DA) or dihydrorhodamine oxidation), extracellular ROS (superoxide dismutase (SOD)&#x02010;inhibitable cytochrome C reduction, lucigenin&#x02010;enhanced chemiluminescence) or total ROS (luminol&#x02010;enhanced chemiluminescence, dihydroethidium assays and DCFH&#x02010;DA assays using plate readers, without addition of membrane&#x02010;impermeable ROS scavengers) [<xref rid="apha70057-bib-0014" ref-type="bibr">14</xref>].</p><p>For the meta&#x02010;analysis, study quality assessment included checking the completeness of the description of the patient population and the methods. Study size and values with mean and standard deviation (SD) or standard error of the mean (SEM) were extracted from the manuscript text, tables or graphical representations (J.S.L., double&#x02010;checked by S.V./P.M.). SEM was converted to SD for inclusion in the meta&#x02010;analysis. Furthermore, an N&#x02010;number correction for multiple comparisons was applied where appropriate (i.e., when multiple CKD cohorts were compared to the same control group or when the same parameter (e.g., intracellular ROS) was measured in different ways).</p></sec><sec id="apha70057-sec-0009"><label>2.3</label><title>Meta&#x02010;Analysis: Calculation and Statistical Analysis</title><p>Statistical analysis and graphical representation were performed in Rstudio v1.3.1093 using the &#x02018;meta&#x02019;, &#x02018;metafor&#x02019; and &#x02018;dmetar&#x02019; packages [<xref rid="apha70057-bib-0015" ref-type="bibr">15</xref>, <xref rid="apha70057-bib-0016" ref-type="bibr">16</xref>]. The effect size of neutrophil ROS production in CKD patients vs. controls was calculated as standardized mean difference using Hedge's g with 95% confidence intervals. As we anticipated considerable between&#x02010;study heterogeneity, the data were pooled using a random effects model (Hartung&#x02010;Knapp&#x02010;Sidik&#x02010;Jonkman). <italic toggle="yes">I</italic>
<sup>2</sup> was reported as a measure for heterogeneity across studies. As influencer outlier analysis, a Baujat plot and leave&#x02010;one&#x02010;out analysis were performed. Potential publication bias was examined in a funnel plot and Egger's test.</p></sec></sec><sec sec-type="results" id="apha70057-sec-0010"><label>3</label><title>Results</title><sec id="apha70057-sec-0011"><label>3.1</label><title>Neutrophil Functional Changes in <styled-content style="fixed-case" toggle="no">CKD</styled-content>: A Systematic Review</title><p>Using defined search and eligibility criteria (Table&#x000a0;<xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S1</xref>), we identified 524 articles examining neutrophil function in CKD. After exclusion of duplicates, non&#x02010;English, and non&#x02010;original publications, and after an initial screening based on title and abstract, the full text of 238 articles was assessed. Of these, 146 were excluded because they only measured neutrophil&#x02010;to&#x02010;lymphocyte ratio or neutrophil numbers (<italic toggle="yes">n</italic>&#x02009;=&#x02009;74), used patient material other than blood (<italic toggle="yes">n</italic>&#x02009;=&#x02009;30), had no healthy control group (<italic toggle="yes">n</italic>&#x02009;=&#x02009;41) or used a non&#x02010;adult control group vs. an adult patient group (<italic toggle="yes">n</italic>&#x02009;=&#x02009;1). Thus, 92 studies were included in the systematic review (Figure&#x000a0;<xref rid="apha70057-fig-0001" ref-type="fig">1</xref>). The most studied neutrophil response was ROS generation (<italic toggle="yes">n</italic>&#x02009;=&#x02009;25), followed by phagocytosis (<italic toggle="yes">n</italic>&#x02009;=&#x02009;19), surface marker expression (<italic toggle="yes">n</italic>&#x02009;=&#x02009;14), apoptosis (<italic toggle="yes">n</italic>&#x02009;=&#x02009;9), degranulation (<italic toggle="yes">n</italic>&#x02009;=&#x02009;8) and NET formation (<italic toggle="yes">n</italic>&#x02009;=&#x02009;4).</p><p>Figure&#x000a0;<xref rid="apha70057-fig-0002" ref-type="fig">2</xref> and Table&#x000a0;<xref rid="apha70057-tbl-0001" ref-type="table">1</xref> visually summarize the overall findings of the systematic review. Table&#x000a0;<xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S2</xref> classifies the individual studies according to their effect (increase, decrease, unaltered) on each of the neutrophil readouts, whereas Tables&#x000a0;<xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S3&#x02013;S8</xref> provide full study details for each of the neutrophil readouts. A more detailed results description with additional details on the individual findings is provided in the <xref rid="apha70057-supitem-0001" ref-type="supplementary-material">Supplementary Results</xref>.</p><fig position="float" fig-type="FIGURE" id="apha70057-fig-0002"><label>FIGURE 2</label><caption><p>Summary of studies reporting on neutrophil parameters in specific CKD patient cohorts (compared to healthy controls). Graphical summary of Table&#x000a0;<xref rid="apha70057-tbl-0002" ref-type="table">2</xref>. &#x0201c;Inconclusive&#x0201d; indicates no overall conclusion due to insufficient study number. CKD, chronic kidney disease; HD, hemodialysis; NET, neutrophil extracellular traps; n.s., not specified; PD, peritoneal dialysis; ROS, reactive oxygen species.</p></caption><graphic xlink:href="APHA-241-e70057-g002" position="anchor" id="jats-graphic-3"/></fig><table-wrap position="float" id="apha70057-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Summary of studies reporting on neutrophil parameters in specific CKD patient cohorts (compared to healthy controls).</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Neutrophil response</th><th align="center" colspan="3" valign="bottom" rowspan="1">Non&#x02010;dialysis CKD</th><th align="center" colspan="3" valign="bottom" rowspan="1">Peritoneal dialysis</th><th align="center" colspan="3" valign="bottom" rowspan="1">Hemodialysis</th><th align="center" colspan="2" valign="bottom" rowspan="1">CKD: mixed<xref rid="apha70057-note-0006" ref-type="table-fn">
<sup>d</sup>
</xref> or n.s.</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Phagocytosis</td><td align="center" colspan="2" style="background-color:#E7E6E6" valign="top" rowspan="1">4/6</td><td align="center" style="background-color:#8EA9DB" valign="top" rowspan="1" colspan="1">2/6</td><td align="center" colspan="3" style="background-color:#E7E6E6" valign="top" rowspan="1">5/5</td><td align="center" style="background-color:#E7E6E6" valign="top" rowspan="1" colspan="1">5/15</td><td align="center" colspan="2" style="background-color:#8EA9DB" valign="top" rowspan="1">10/15</td><td align="center" style="background-color:#F4B084" valign="top" rowspan="1" colspan="1">1/2</td><td align="center" style="background-color:#8EA9DB" valign="top" rowspan="1" colspan="1">1/2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Apoptosis (basal)</td><td align="center" colspan="3" style="background-color:#F4B084" valign="top" rowspan="1">5/5</td><td align="center" colspan="2" style="background-color:#E7E6E6" valign="top" rowspan="1">2/3</td><td align="center" style="background-color:#F4B084" valign="top" rowspan="1" colspan="1">1/3</td><td align="center" colspan="2" style="background-color:#E7E6E6" valign="top" rowspan="1">5/8</td><td align="center" style="background-color:#F4B084" valign="top" rowspan="1" colspan="1">3/8</td><td align="center" colspan="2" valign="top" rowspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Surface activation markers<xref rid="apha70057-note-0003" ref-type="table-fn">
<sup>a</sup>
</xref> (basal)</td><td align="center" colspan="2" style="background-color:#F4B084" valign="top" rowspan="1">4/5</td><td align="center" style="background-color:#8EA9DB" valign="top" rowspan="1" colspan="1">1/5</td><td align="center" colspan="3" valign="top" rowspan="1">&#x02014;</td><td align="center" colspan="2" style="background-color:#E7E6E6" valign="top" rowspan="1">4/8</td><td align="center" style="background-color:#F4B084" valign="top" rowspan="1" colspan="1">4/8</td><td align="center" colspan="2" style="background-color:#F4B084" valign="top" rowspan="1">1/1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Surface activation markers<xref rid="apha70057-note-0003" ref-type="table-fn">
<sup>a</sup>
</xref> (stimulated)</td><td align="center" colspan="3" style="background-color:#F4B084" valign="top" rowspan="1">2/2 (LPS, fMLP)</td><td align="center" colspan="3" valign="top" rowspan="1">&#x02014;</td><td align="center" colspan="3" style="background-color:#E7E6E6" valign="top" rowspan="1">1/1 (IL8)</td><td align="center" colspan="2" style="background-color:#F4B084" valign="top" rowspan="1">1/1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Degranulation (plasma markers)<xref rid="apha70057-note-0004" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" colspan="3" style="background-color:#E7E6E6" valign="top" rowspan="1">1/1</td><td align="center" colspan="3" valign="top" rowspan="1">&#x02014;</td><td align="center" colspan="3" style="background-color:#F4B084" valign="top" rowspan="1">5/5</td><td align="center" colspan="2" style="background-color:#F4B084" valign="top" rowspan="1">1/1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Degranulation (neutrophil readouts)<xref rid="apha70057-note-0004" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="center" colspan="3" valign="top" rowspan="1">&#x02014;</td><td align="center" colspan="3" valign="top" rowspan="1">&#x02014;</td><td align="center" style="background-color:#E7E6E6" valign="top" rowspan="1" colspan="1">1/4</td><td align="center" colspan="2" style="background-color:#F4B084" valign="top" rowspan="1">3/4</td><td align="center" colspan="2" valign="top" rowspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NET formation (basal)</td><td align="center" colspan="3" valign="top" rowspan="1">&#x02014;</td><td align="center" colspan="3" valign="top" rowspan="1">&#x02014;</td><td align="center" style="background-color:#E7E6E6" valign="top" rowspan="1" colspan="1">1/3</td><td align="center" colspan="2" style="background-color:#F4B084" valign="top" rowspan="1">2/3</td><td align="center" colspan="2" style="background-color:#E7E6E6" valign="top" rowspan="1">1/1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NET formation (stimulated)</td><td align="center" colspan="3" valign="top" rowspan="1">&#x02014;</td><td align="center" colspan="3" valign="top" rowspan="1">&#x02014;</td><td align="center" style="background-color:#E7E6E6" valign="top" rowspan="1" colspan="1">1/3</td><td align="center" style="background-color:#F4B084" valign="top" rowspan="1" colspan="1">1/3</td><td align="center" style="background-color:#8EA9DB" valign="top" rowspan="1" colspan="1">1/3</td><td align="center" colspan="2" style="background-color:#E7E6E6" valign="top" rowspan="1">1/1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ROS production (basal)</td><td align="center" colspan="3" style="background-color:#E7E6E6" valign="top" rowspan="1">4/4</td><td align="center" colspan="3" style="background-color:#E7E6E6" valign="top" rowspan="1">2/2</td><td align="center" style="background-color:#F4B084" valign="top" rowspan="1" colspan="1">8/12</td><td align="center" style="background-color:#D0CECE" valign="top" rowspan="1" colspan="1">3/12</td><td align="center" style="background-color:#8EA9DB" valign="top" rowspan="1" colspan="1">1/12</td><td align="center" colspan="2" valign="top" rowspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ROS production (stimulation)<xref rid="apha70057-note-0005" ref-type="table-fn">
<sup>c</sup>
</xref>
</td><td align="center" style="background-color:#F4B084" valign="top" rowspan="1" colspan="1">3/7</td><td align="center" style="background-color:#E7E6E6" valign="top" rowspan="1" colspan="1">2/7</td><td align="center" style="background-color:#8EA9DB" valign="top" rowspan="1" colspan="1">3/7</td><td align="center" style="background-color:#F4B084" valign="top" rowspan="1" colspan="1">3/5</td><td align="center" style="background-color:#E7E6E6" valign="top" rowspan="1" colspan="1">2/5</td><td align="center" style="background-color:#8EA9DB" valign="top" rowspan="1" colspan="1">1/5</td><td align="center" style="background-color:#F4B084" valign="top" rowspan="1" colspan="1">7/17</td><td align="center" style="background-color:#E7E6E6" valign="top" rowspan="1" colspan="1">2/17</td><td align="center" style="background-color:#8EA9DB" valign="top" rowspan="1" colspan="1">9/17</td><td align="center" colspan="2" valign="top" rowspan="1">&#x02014;</td></tr></tbody></table><table frame="hsides" rules="groups"><col align="left" span="1"/><tbody valign="top"><tr><td align="left" style="background-color:#F4B084" valign="top" rowspan="1" colspan="1">Increased</td></tr><tr><td align="left" style="background-color:#E7E6E6" valign="top" rowspan="1" colspan="1">Unaltered</td></tr><tr><td align="left" style="background-color:#8EA9DB" valign="top" rowspan="1" colspan="1">Reduced</td></tr></tbody></table><table-wrap-foot id="apha70057-ntgp-0002"><fn id="apha70057-note-1002"><p>
<italic toggle="yes">Note:</italic> The colors indicate whether the reported neutrophil response in specific CKD patient cohorts is increased, unaltered or reduced compared to healthy controls. (orange = increased, grey = unaltered, blue = reduced).</p></fn><fn id="apha70057-note-0002"><p>Abbreviations: CKD, chronic kidney disease; NET, neutrophil extracellular traps; n.s., not specified; ROS, reactive oxygen species.</p></fn><fn id="apha70057-note-0003"><label>
<sup>a</sup>
</label><p>With inclusion of only CD11b, CD18, CD66b, and CD88 (Counted as increased if at least one of these was increased).</p></fn><fn id="apha70057-note-0004"><label>
<sup>b</sup>
</label><p>Counted as increased if at least one of the markers was increased.</p></fn><fn id="apha70057-note-0005"><label>
<sup>c</sup>
</label><p>Counted as increased (decreased) if at least with one of the stimuli, increased (decreased) ROS was observed in patients vs. controls. Thus, for a study with both an increased and decreased result depending on the stimulus, the study was counted in for both increased and decreased effects. Studies were counted as &#x0201c;unaltered&#x0201d; only if none of the tested conditions showed an increase or decrease in patients vs. controls.</p></fn><fn id="apha70057-note-0006"><label>
<sup>d</sup>
</label><p>Mixed non&#x02010;dialysis CKD, peritoneal dialysis, hemodialysis.</p></fn></table-wrap-foot></table-wrap></sec><sec id="apha70057-sec-0012"><label>3.2</label><title>Phagocytosis</title><p>Neutrophil phagocytic capacity was mostly found unaltered in non&#x02010;dialysis CKD patients (unaltered: <italic toggle="yes">n</italic>&#x02009;=&#x02009;4 studies [<xref rid="apha70057-bib-0029" ref-type="bibr">29</xref>, <xref rid="apha70057-bib-0034" ref-type="bibr">34</xref>, <xref rid="apha70057-bib-0035" ref-type="bibr">35</xref>, <xref rid="apha70057-bib-0036" ref-type="bibr">36</xref>]; vs. reduced: <italic toggle="yes">n</italic>&#x02009;=&#x02009;2 studies [<xref rid="apha70057-bib-0027" ref-type="bibr">27</xref>, <xref rid="apha70057-bib-0037" ref-type="bibr">37</xref>]) and in CKD patients on PD (unaltered: <italic toggle="yes">n</italic>&#x02009;=&#x02009;5 [<xref rid="apha70057-bib-0027" ref-type="bibr">27</xref>, <xref rid="apha70057-bib-0029" ref-type="bibr">29</xref>, <xref rid="apha70057-bib-0034" ref-type="bibr">34</xref>, <xref rid="apha70057-bib-0035" ref-type="bibr">35</xref>, <xref rid="apha70057-bib-0037" ref-type="bibr">37</xref>]). Instead, it was reduced in 67% (10 of 15) of studies in dialysis patients on HD (reduced: <italic toggle="yes">n</italic>&#x02009;=&#x02009;10 [<xref rid="apha70057-bib-0029" ref-type="bibr">29</xref>, <xref rid="apha70057-bib-0030" ref-type="bibr">30</xref>, <xref rid="apha70057-bib-0034" ref-type="bibr">34</xref>, <xref rid="apha70057-bib-0035" ref-type="bibr">35</xref>, <xref rid="apha70057-bib-0036" ref-type="bibr">36</xref>, <xref rid="apha70057-bib-0038" ref-type="bibr">38</xref>, <xref rid="apha70057-bib-0039" ref-type="bibr">39</xref>, <xref rid="apha70057-bib-0040" ref-type="bibr">40</xref>, <xref rid="apha70057-bib-0041" ref-type="bibr">41</xref>, <xref rid="apha70057-bib-0042" ref-type="bibr">42</xref>] vs. unaltered: <italic toggle="yes">n</italic>&#x02009;=&#x02009;5 [<xref rid="apha70057-bib-0025" ref-type="bibr">25</xref>, <xref rid="apha70057-bib-0043" ref-type="bibr">43</xref>, <xref rid="apha70057-bib-0044" ref-type="bibr">44</xref>, <xref rid="apha70057-bib-0045" ref-type="bibr">45</xref>, <xref rid="apha70057-bib-0046" ref-type="bibr">46</xref>]) (Figure&#x000a0;<xref rid="apha70057-fig-0002" ref-type="fig">2</xref>, Tables&#x000a0;<xref rid="apha70057-tbl-0001" ref-type="table">1</xref>, <xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S2</xref> and <xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S3</xref>).</p></sec><sec id="apha70057-sec-0013"><label>3.3</label><title>Apoptosis</title><p>Neutrophil apoptosis was increased consistently in non&#x02010;dialysis CKD patients [<xref rid="apha70057-bib-0013" ref-type="bibr">13</xref>, <xref rid="apha70057-bib-0029" ref-type="bibr">29</xref>, <xref rid="apha70057-bib-0047" ref-type="bibr">47</xref>, <xref rid="apha70057-bib-0048" ref-type="bibr">48</xref>, <xref rid="apha70057-bib-0049" ref-type="bibr">49</xref>], but only in a subset of studies in CKD patients on HD or PD (increased in HD [<xref rid="apha70057-bib-0013" ref-type="bibr">13</xref>, <xref rid="apha70057-bib-0049" ref-type="bibr">49</xref>, <xref rid="apha70057-bib-0050" ref-type="bibr">50</xref>] or increased in PD [<xref rid="apha70057-bib-0013" ref-type="bibr">13</xref>], vs. unaltered in HD [<xref rid="apha70057-bib-0020" ref-type="bibr">20</xref>, <xref rid="apha70057-bib-0026" ref-type="bibr">26</xref>, <xref rid="apha70057-bib-0029" ref-type="bibr">29</xref>, <xref rid="apha70057-bib-0048" ref-type="bibr">48</xref>, <xref rid="apha70057-bib-0051" ref-type="bibr">51</xref>] or PD [<xref rid="apha70057-bib-0029" ref-type="bibr">29</xref>, <xref rid="apha70057-bib-0048" ref-type="bibr">48</xref>]; Figure&#x000a0;<xref rid="apha70057-fig-0002" ref-type="fig">2</xref>, Tables&#x000a0;<xref rid="apha70057-tbl-0001" ref-type="table">1</xref>, <xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S2</xref> and <xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S4</xref>).</p></sec><sec id="apha70057-sec-0014"><label>3.4</label><title>Surface Activation Markers</title><p>CD11b, CD18, CD66b, and CD88 were the most frequently studied activation markers on neutrophils in CKD. Their analysis revealed generally increased neutrophil activation in non&#x02010;dialysis CKD patients in both basal conditions (increased: <italic toggle="yes">n</italic>&#x02009;=&#x02009;4 [<xref rid="apha70057-bib-0049" ref-type="bibr">49</xref>, <xref rid="apha70057-bib-0052" ref-type="bibr">52</xref>, <xref rid="apha70057-bib-0053" ref-type="bibr">53</xref>, <xref rid="apha70057-bib-0054" ref-type="bibr">54</xref>] vs. reduced: <italic toggle="yes">n</italic>&#x02009;=&#x02009;1 [<xref rid="apha70057-bib-0055" ref-type="bibr">55</xref>]) as well as in conditions of stimulation (increased: <italic toggle="yes">n</italic>&#x02009;=&#x02009;2 [<xref rid="apha70057-bib-0053" ref-type="bibr">53</xref>, <xref rid="apha70057-bib-0054" ref-type="bibr">54</xref>]). In contrast, neutrophils from HD patients showed in basal conditions only in half of the studies an increase in (at least some of) these four activation markers (increased: <italic toggle="yes">n</italic>&#x02009;=&#x02009;4 [<xref rid="apha70057-bib-0018" ref-type="bibr">18</xref>, <xref rid="apha70057-bib-0030" ref-type="bibr">30</xref>, <xref rid="apha70057-bib-0033" ref-type="bibr">33</xref>, <xref rid="apha70057-bib-0049" ref-type="bibr">49</xref>]; unaltered: <italic toggle="yes">n</italic>&#x02009;=&#x02009;4 [<xref rid="apha70057-bib-0022" ref-type="bibr">22</xref>, <xref rid="apha70057-bib-0052" ref-type="bibr">52</xref>, <xref rid="apha70057-bib-0056" ref-type="bibr">56</xref>, <xref rid="apha70057-bib-0057" ref-type="bibr">57</xref>]). Insufficient data are available on stimulated neutrophils in HD patients (<italic toggle="yes">n</italic>&#x02009;=&#x02009;1: unaltered [<xref rid="apha70057-bib-0056" ref-type="bibr">56</xref>]) as well as on neutrophils from PD patients (Figure&#x000a0;<xref rid="apha70057-fig-0002" ref-type="fig">2</xref>, Tables&#x000a0;<xref rid="apha70057-tbl-0001" ref-type="table">1</xref>, <xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S2</xref> and <xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S5</xref>).</p></sec><sec id="apha70057-sec-0015"><label>3.5</label><title>Degranulation</title><p>Degranulation refers to the active release of granule contents in response to neutrophil stimulation. In addition to (i) an increased MPO or neutrophil elastase release upon neutrophil stimulation, we also included in this chapter the following readouts reported in the identified studies: (ii) reduced basal levels of MPO or neutrophil elastase in neutrophils, and (iii) increased levels of neutrophil elastase, MPO, lactoferrin, or histone&#x02010;DNA in blood. All studies observed an increase in at least one of these readouts in either blood or isolated neutrophils in CKD patients compared to healthy controls (<italic toggle="yes">n</italic>&#x02009;=&#x02009;8: 7&#x000d7; HD patients; 1&#x000d7; unspecified CKD stage) [<xref rid="apha70057-bib-0024" ref-type="bibr">24</xref>, <xref rid="apha70057-bib-0030" ref-type="bibr">30</xref>, <xref rid="apha70057-bib-0058" ref-type="bibr">58</xref>, <xref rid="apha70057-bib-0059" ref-type="bibr">59</xref>, <xref rid="apha70057-bib-0060" ref-type="bibr">60</xref>, <xref rid="apha70057-bib-0061" ref-type="bibr">61</xref>, <xref rid="apha70057-bib-0062" ref-type="bibr">62</xref>, <xref rid="apha70057-bib-0063" ref-type="bibr">63</xref>]. Only one study compared both non&#x02010;dialysis CKD and HD patients to healthy controls, revealing increased plasma MPO levels only in HD patients [<xref rid="apha70057-bib-0060" ref-type="bibr">60</xref>] (Figure&#x000a0;<xref rid="apha70057-fig-0002" ref-type="fig">2</xref>, Tables&#x000a0;<xref rid="apha70057-tbl-0001" ref-type="table">1</xref>, <xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S2</xref> and <xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S6</xref>).</p></sec><sec id="apha70057-sec-0016"><label>3.6</label><title>
<styled-content style="fixed-case" toggle="no">NET</styled-content> Formation</title><p>Overall, highly variable data were observed for NET formation by neutrophils from HD patients (basal NET formation: increased: <italic toggle="yes">n</italic>&#x02009;=&#x02009;2 [<xref rid="apha70057-bib-0022" ref-type="bibr">22</xref>, <xref rid="apha70057-bib-0064" ref-type="bibr">64</xref>] vs. unaltered: <italic toggle="yes">n</italic>&#x02009;=&#x02009;1 [<xref rid="apha70057-bib-0030" ref-type="bibr">30</xref>]; stimulated NET formation: increased: <italic toggle="yes">n</italic>&#x02009;=&#x02009;1 [<xref rid="apha70057-bib-0064" ref-type="bibr">64</xref>]; decreased: <italic toggle="yes">n</italic>&#x02009;=&#x02009;1 [<xref rid="apha70057-bib-0030" ref-type="bibr">30</xref>]; unaltered: <italic toggle="yes">n</italic>&#x02009;=&#x02009;1 [<xref rid="apha70057-bib-0022" ref-type="bibr">22</xref>, <xref rid="apha70057-bib-0065" ref-type="bibr">65</xref>]; Figure&#x000a0;<xref rid="apha70057-fig-0002" ref-type="fig">2</xref>, Tables&#x000a0;<xref rid="apha70057-tbl-0001" ref-type="table">1</xref>, <xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S2</xref> and <xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S7</xref>). No comparison was possible to PD patients or non&#x02010;dialysis CKD patients due to a lack of data.</p></sec><sec id="apha70057-sec-0017"><label>3.7</label><title>
<styled-content style="fixed-case" toggle="no">ROS</styled-content> Production</title><p>In basal, unstimulated conditions, an increased ROS production was observed in 8 of 12 studies on HD patients, whereas no changes were detected in non&#x02010;dialysis CKD patients (<italic toggle="yes">n</italic>&#x02009;=&#x02009;4) or PD patients (<italic toggle="yes">n</italic>&#x02009;=&#x02009;2). In conditions of neutrophil stimulation, findings on ROS production were highly variable in both non&#x02010;dialysis as well as PD and HD patients (Figure&#x000a0;<xref rid="apha70057-fig-0002" ref-type="fig">2</xref>, Tables&#x000a0;<xref rid="apha70057-tbl-0001" ref-type="table">1</xref>, <xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S2</xref> and <xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S8</xref>). Neutrophils produce ROS mainly via the NADPH oxidase 2 (NOX2) at the plasma membrane or in intracellular compartments, producing extracellular and/or intracellular ROS [<xref rid="apha70057-bib-0014" ref-type="bibr">14</xref>]. Furthermore, different stimuli have been used to analyze neutrophil ROS production. Since this may add to the observed data variability, we subsequently performed a meta&#x02010;analysis of neutrophil ROS production with subgroup analyses.</p><p>In summary, the systematic review identified primarily reduced phagocytosis capacity but increased neutrophil degranulation and basal ROS production in neutrophils from CKD patients on hemodialysis compared to controls (Figure&#x000a0;<xref rid="apha70057-fig-0002" ref-type="fig">2</xref>). Instead, phagocytosis and basal ROS production were mainly unaltered in non&#x02010;dialysis&#x02010;dependent CKD patients and CKD patients on peritoneal dialysis (Figure&#x000a0;<xref rid="apha70057-fig-0002" ref-type="fig">2</xref>).</p></sec><sec id="apha70057-sec-0018"><label>3.8</label><title>Neutrophil <styled-content style="fixed-case" toggle="no">ROS</styled-content> Production in <styled-content style="fixed-case" toggle="no">CKD</styled-content>: A Meta&#x02010;Analysis</title><p>With ROS production being the most studied neutrophil readout and an important contributor to CVD pathophysiology, we performed a meta&#x02010;analysis on ROS generation to summarize the available data and enable subgroup analyses to identify potential factors contributing to data heterogeneity in current literature. Since only eight studies investigated non&#x02010;dialysis dependent CKD patients, the meta&#x02010;analysis focused on ROS in dialysis patients (<italic toggle="yes">n</italic>&#x02009;=&#x02009;24 studies, with patients either on HD or PD). A total of 18 studies used comparable methods for ROS measurements and provided sufficient details on datasets for inclusion in the meta&#x02010;analysis (Figure&#x000a0;<xref rid="apha70057-fig-0001" ref-type="fig">1</xref>, Table&#x000a0;<xref rid="apha70057-tbl-0002" ref-type="table">2</xref>). The other studies had to be excluded based on incomparable assay use (<italic toggle="yes">n</italic>&#x02009;=&#x02009;4; assays: oxygen consumption by Clark electrode, <styled-content style="fixed-case" toggle="no">
<italic toggle="no">C. albicans</italic>
</styled-content> as only stimulus, C5a and FLPEP as only stimulus, experimental setup unclear), insufficient data sets (<italic toggle="yes">n</italic>&#x02009;=&#x02009;2: number of controls unclear, results only shown as median) and patients reported to be only on newly initiated dialysis (<italic toggle="yes">n</italic>&#x02009;=&#x02009;1) (Figure&#x000a0;<xref rid="apha70057-fig-0001" ref-type="fig">1</xref>, Table&#x000a0;<xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S1</xref>).</p><table-wrap position="float" id="apha70057-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Characteristics of studies analyzing neutrophil ROS production in dialysis patients, as included in the meta&#x02010;analysis.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" valign="bottom" colspan="1">Study</th><th align="center" rowspan="2" valign="bottom" colspan="1">Patient cohort</th><th align="center" rowspan="2" valign="bottom" colspan="1">Neutrophils in full blood/isolated neutrophils</th><th align="center" rowspan="2" valign="bottom" colspan="1">ROS Assay (I, intracellular) (E, extracellular) (T, total)</th><th align="center" rowspan="2" valign="bottom" colspan="1">Stimulus</th><th align="center" valign="bottom" rowspan="1" colspan="1">Overall study conclusion on ROS response in patients compared to healthy controls</th><th align="center" rowspan="2" valign="bottom" colspan="1">Dialysis procedure</th></tr><tr style="border-bottom:solid 1px #000000"><th align="center" valign="bottom" rowspan="1" colspan="1">(Basal/Stimulated)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Cohen et&#x000a0;al. [<xref rid="apha70057-bib-0017" ref-type="bibr">17</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">HD</td><td align="center" valign="top" rowspan="1" colspan="1">Full blood analysis</td><td align="center" valign="top" rowspan="1" colspan="1">DHR oxidation (FC) (I)</td><td align="center" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">E. coli</italic> &#x00026; PMA</td><td align="center" valign="top" rowspan="1" colspan="1">Decreased (stimulated)</td><td align="center" valign="top" rowspan="1" colspan="1">High&#x02010;flux membranes (nitrocellulose triacetate)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cohen&#x02010;Mazor et&#x000a0;al. [<xref rid="apha70057-bib-0018" ref-type="bibr">18</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">HD</td><td align="center" valign="top" rowspan="1" colspan="1">PMNL</td><td align="center" valign="top" rowspan="1" colspan="1">SOD&#x02010;inhibitable cytochrome c reduction (E)</td><td align="center" valign="top" rowspan="1" colspan="1">PMA</td><td align="center" valign="top" rowspan="1" colspan="1">Increased (stimulated)</td><td align="center" valign="top" rowspan="1" colspan="1">Low&#x02010;flux polysulfone membranes</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cohen&#x02010;Hagai et&#x000a0;al. [<xref rid="apha70057-bib-0019" ref-type="bibr">19</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">HD</td><td align="center" valign="top" rowspan="1" colspan="1">Full blood analysis</td><td align="center" valign="top" rowspan="1" colspan="1">DHR oxidation (FC) (I)</td><td align="center" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">E. coli</italic> &#x00026; PMA</td><td align="center" valign="top" rowspan="1" colspan="1">Decreased (stimulated)</td><td align="center" valign="top" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Guo et&#x000a0;al. [<xref rid="apha70057-bib-0020" ref-type="bibr">20</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">HD</td><td align="center" valign="top" rowspan="1" colspan="1">PMNL</td><td align="center" valign="top" rowspan="1" colspan="1">DCFH&#x02010;DA oxidation (FC) (I)</td><td align="center" valign="top" rowspan="1" colspan="1">PMA, fMLP &#x00026; <italic toggle="yes">S. aureus</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1">Increased (unstimulated + stimulated with <italic toggle="yes">S. aureus</italic> and fMLP), unaltered (stimulated with PMA)</td><td align="center" valign="top" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Haynes et&#x000a0;al. [<xref rid="apha70057-bib-0021" ref-type="bibr">21</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">PD</td><td align="center" valign="top" rowspan="1" colspan="1">PMNL</td><td align="center" valign="top" rowspan="1" colspan="1">Lucigenin&#x02010;enhanced chemiluminescence (E)</td><td align="center" valign="top" rowspan="1" colspan="1">fMLP</td><td align="center" valign="top" rowspan="1" colspan="1">Increased (stimulated)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Kim et&#x000a0;al. [<xref rid="apha70057-bib-0022" ref-type="bibr">22</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">HD</td><td align="center" valign="top" rowspan="1" colspan="1">PMNL</td><td align="center" valign="top" rowspan="1" colspan="1">DCFH&#x02010;DA oxidation (plate reader) (T)</td><td align="center" valign="top" rowspan="1" colspan="1">Unstimulated</td><td align="center" valign="top" rowspan="1" colspan="1">Increased (unstimulated)</td><td align="center" valign="top" rowspan="1" colspan="1">Standard bicarbonate dialysis &#x00026; semisynthetic membranes</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Kristal et&#x000a0;al. [<xref rid="apha70057-bib-0023" ref-type="bibr">23</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">HD</td><td align="center" valign="top" rowspan="1" colspan="1">PMNL</td><td align="center" valign="top" rowspan="1" colspan="1">SOD&#x02010;inhibitable cytochrome c reduction (E)</td><td align="center" valign="top" rowspan="1" colspan="1">PMA</td><td align="center" valign="top" rowspan="1" colspan="1">Increased (stimulated)</td><td align="center" valign="top" rowspan="1" colspan="1">Polysulfone or cellulose triacetate dialysis membranes</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Otaki et&#x000a0;al. [<xref rid="apha70057-bib-0024" ref-type="bibr">24</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">HD</td><td align="center" valign="top" rowspan="1" colspan="1">PMNL</td><td align="center" valign="top" rowspan="1" colspan="1">DCFH&#x02010;DA oxidation (FC) (I)</td><td align="center" valign="top" rowspan="1" colspan="1">Unstimulated</td><td align="center" valign="top" rowspan="1" colspan="1">Unaltered (unstimulated)</td><td align="center" valign="top" rowspan="1" colspan="1">Either cellulose triacetate, excebrane, or polymethylmethacrylate membranes and bicarbonate dialysate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patruta et&#x000a0;al. [<xref rid="apha70057-bib-0025" ref-type="bibr">25</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">HD</td><td align="center" valign="top" rowspan="1" colspan="1">PMNL</td><td align="center" valign="top" rowspan="1" colspan="1">SOD&#x02010;inhibitable cytochrome c reduction (E)</td><td align="center" valign="top" rowspan="1" colspan="1">PMA</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>Increased (unstimulated)</p>
<p>Decreased (stimulated)</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">Bicarbonate hemodialysis using biocompatible membrane material made of polysulfone or cellulose triacetate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Perianayagam et&#x000a0;al. [<xref rid="apha70057-bib-0026" ref-type="bibr">26</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">HD</td><td align="center" valign="top" rowspan="1" colspan="1">Full blood analysis</td><td align="center" valign="top" rowspan="1" colspan="1">DCFH&#x02010;DA oxidation (FC) (I)</td><td align="center" valign="top" rowspan="1" colspan="1">Unstimulated</td><td align="center" valign="top" rowspan="1" colspan="1">Increased (unstimulated)</td><td align="center" valign="top" rowspan="1" colspan="1">High&#x02010;flux dialyzers</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Porter et&#x000a0;al. [<xref rid="apha70057-bib-0027" ref-type="bibr">27</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">PD</td><td align="center" valign="top" rowspan="1" colspan="1">PMNL</td><td align="center" valign="top" rowspan="1" colspan="1">Luminol&#x02010;enhanced chemiluminescence (T); DCFH&#x02010;DA oxidation (FC) (I)</td><td align="center" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">S. epidermidis</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1">Unaltered (stimulated)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rao et&#x000a0;al. [<xref rid="apha70057-bib-0028" ref-type="bibr">28</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">HD</td><td align="center" valign="top" rowspan="1" colspan="1">PMNL</td><td align="center" valign="top" rowspan="1" colspan="1">SOD&#x02010;inhibitable cytochrome c reduction (E)</td><td align="center" valign="top" rowspan="1" colspan="1">PMA, fMLP</td><td align="center" valign="top" rowspan="1" colspan="1">Decreased (stimulated PMA), unaltered (stimulated fMLP)</td><td align="center" valign="top" rowspan="1" colspan="1">Polysulphone (PS), cuprophane (CU), cellulose (acetate, triacetate) (CA/CT)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sardenberg et&#x000a0;al. [<xref rid="apha70057-bib-0029" ref-type="bibr">29</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>HD</p>
<p>PD</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">Full blood analysis</td><td align="center" valign="top" rowspan="1" colspan="1">DCFH&#x02010;DA oxidation (FC) (I)</td><td align="center" valign="top" rowspan="1" colspan="1">Unstimulated, <italic toggle="yes">S. aureus</italic>, PMA, fMLP</td><td align="center" valign="top" rowspan="1" colspan="1">Increased (stimulated with bacterial and fMLP+basal for CAPD), Unaltered (stimulated + unstimulated HD, stimulated with PMA for CAPD)</td><td align="center" valign="top" rowspan="1" colspan="1">HD: polysulfone dialyzers CAPD: exchanges of glucose, lactate&#x02010;based solutions that usually included one 4.25% glucose solution exchange</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sela et&#x000a0;al. [<xref rid="apha70057-bib-0013" ref-type="bibr">13</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">
<p>PD</p>
<p>HD</p>
</td><td align="center" valign="top" rowspan="1" colspan="1">PMNL</td><td align="center" valign="top" rowspan="1" colspan="1">SOD&#x02010;inhibitable cytochrome c reduction (E)</td><td align="center" valign="top" rowspan="1" colspan="1">unstimulated, PMA, Zymosan</td><td align="center" valign="top" rowspan="1" colspan="1">Increased (stimulated PMA), Decreased (stimulated Zymosan)</td><td align="center" valign="top" rowspan="1" colspan="1">CAPD: 8&#x02009;L/d in four exchanges (three isotonic 1.36% and one hypertonic 3.86% glucose solutions); HD: low&#x02010;flux polysulfone membranes with bicarbonate dialysate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Talal et&#x000a0;al. [<xref rid="apha70057-bib-0030" ref-type="bibr">30</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">HD</td><td align="center" valign="top" rowspan="1" colspan="1">Neutrophils</td><td align="center" valign="top" rowspan="1" colspan="1">Extracellular ROS with chemilumescence (E)</td><td align="center" valign="top" rowspan="1" colspan="1">PMA, LPS</td><td align="center" valign="top" rowspan="1" colspan="1">Decreased (stimulated)</td><td align="center" valign="top" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ward et&#x000a0;al. [<xref rid="apha70057-bib-0031" ref-type="bibr">31</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">HD</td><td align="center" valign="top" rowspan="1" colspan="1">PMNL</td><td align="center" valign="top" rowspan="1" colspan="1">Cytochrome c reduction (E)</td><td align="center" valign="top" rowspan="1" colspan="1">TNF, fMLP</td><td align="center" valign="top" rowspan="1" colspan="1">Unaltered (unstimulated), Decreased (stimulated)</td><td align="center" valign="top" rowspan="1" colspan="1">Reused dialyzers containing cellulose acetate membrane</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ward et&#x000a0;al. [<xref rid="apha70057-bib-0032" ref-type="bibr">32</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">HD</td><td align="center" valign="top" rowspan="1" colspan="1">Full blood analysis</td><td align="center" valign="top" rowspan="1" colspan="1">DCFH&#x02010;DA oxidation (FC) (I)</td><td align="center" valign="top" rowspan="1" colspan="1">Unstimulated, <italic toggle="yes">S. aureus</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1">Increased (unstimulated + stimulated)</td><td align="center" valign="top" rowspan="1" colspan="1">High&#x02010;flux dialyzers containing polysulfone and cellulose triacetate membranes</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Yoon et&#x000a0;al. [<xref rid="apha70057-bib-0033" ref-type="bibr">33</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">HD</td><td align="center" valign="top" rowspan="1" colspan="1">Full blood analysis</td><td align="center" valign="top" rowspan="1" colspan="1">DHE oxidation, DHR oxidation (FC) (I)</td><td align="center" valign="top" rowspan="1" colspan="1">Unstimulated</td><td align="center" valign="top" rowspan="1" colspan="1">Increased (unstimulated)</td><td align="center" valign="top" rowspan="1" colspan="1">Cellulose acetate dialyzers</td></tr></tbody></table><table-wrap-foot id="apha70057-ntgp-0003"><fn id="apha70057-note-0007"><p>
<italic toggle="yes">Note:</italic> For ROS location: (I) intracellular; (E) extracellular; (T) total&#x02009;=&#x02009;intra&#x02010; and extracellular. All studies were observational studies.</p></fn><fn id="apha70057-note-0008"><p>Abbreviations: DCFH&#x02010;DA, 2&#x02032;,7&#x02032;&#x02010;dichlorodihydrofluorescein diacetate; DHE, dihydroethidium; DHR, dihydrorhodamine; EDTA, ethylenediaminetetraacetic acid; FC, flow cytometry; HD, hemodialysis; MFI, mean fluorescence intensity; n.s., not specified; obs., observational; PD, peritoneal dialysis; PMNL, polymorphonuclear leukocyte.</p></fn></table-wrap-foot></table-wrap><p>No publication bias was detected (Funnel plot in Figure&#x000a0;<xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S1</xref>; Eggers' test for Funnel plot asymmetry: <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.089). Influential outlier analyses revealed Cohen&#x02010;Hagai et&#x000a0;al. [<xref rid="apha70057-bib-0019" ref-type="bibr">19</xref>] as well as Kim et&#x000a0;al. [<xref rid="apha70057-bib-0022" ref-type="bibr">22</xref>] as studies impacting most on the overall heterogeneity of the meta&#x02010;analysis (Figure&#x000a0;<xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S2A</xref>). However, since these studies were not identified as unique strong influencers of the pooled result in both performed influential outlier tests (Figure&#x000a0;<xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S2A,B</xref>), no studies were excluded from the meta&#x02010;analysis. Overall, the meta&#x02010;analysis showed no significant difference in ROS production between neutrophils of dialysis patients and healthy controls, neither on overall level (Hedges <italic toggle="yes">g</italic>&#x02009;=&#x02009;0.06; 95% CI: [&#x02212;0.54; 0.66]) nor when analyzing specifically intra&#x02010; or extracellular ROS (Figure&#x000a0;<xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S3</xref>, intracellular ROS: Hedges <italic toggle="yes">g</italic>&#x02009;=&#x02009;&#x02212;0.08; 95% CI: [&#x02212;0.95; 0.80]; extracellular ROS: Hedges <italic toggle="yes">g</italic>&#x02009;=&#x02009;0.07; 95% CI: [&#x02212;0.73; 0.88]).</p><p>However, the meta&#x02010;analysis revealed an overall high data heterogeneity (<italic toggle="yes">I</italic>
<sup>2</sup>&#x02009;=&#x02009;93%) and highlighted that even within the same study conflicting results could be detected dependent on the type of dialysis performed [<xref rid="apha70057-bib-0029" ref-type="bibr">29</xref>] (i.e., HD vs. PD), whether resting vs. stimulated neutrophils were examined [<xref rid="apha70057-bib-0025" ref-type="bibr">25</xref>] or dependent on which stimulus was applied [<xref rid="apha70057-bib-0013" ref-type="bibr">13</xref>, <xref rid="apha70057-bib-0020" ref-type="bibr">20</xref>, <xref rid="apha70057-bib-0028" ref-type="bibr">28</xref>, <xref rid="apha70057-bib-0031" ref-type="bibr">31</xref>]. A second meta&#x02010;analysis with subgrouping of studies based on the type of dialysis could not reveal an overall significant difference in neutrophil ROS generation in either HD or PD patients compared to healthy controls (HD: Hedges <italic toggle="yes">g</italic>&#x02009;=&#x02009;&#x02212;0.04, 95% CI: [&#x02212;0.81; 0.73]; PD: Hedges <italic toggle="yes">g</italic>&#x02009;=&#x02009;0.39, 95% CI: [&#x02212;0.09; 0.87], Figure&#x000a0;<xref rid="apha70057-fig-0003" ref-type="fig">3</xref>), but again highlighted the presence and type of stimulus as an important influencing factor.</p><fig position="float" fig-type="FIGURE" id="apha70057-fig-0003"><label>FIGURE 3</label><caption><p>Meta&#x02010;analysis shows no overall significant difference in neutrophil ROS production between CKD patients on either hemodialysis or peritoneal dialysis versus controls. Forest plot of neutrophil ROS production in dialysis patients compared to healthy controls, with subgroup analysis of the effect of dialysis type. CI, confidence interval; CKD, chronic kidney disease; <styled-content style="fixed-case" toggle="no">
<italic toggle="no">E. coli</italic>
</styled-content>, <styled-content style="fixed-case" toggle="no">
<italic toggle="no">Escherichia coli</italic>
</styled-content>; HD, hemodialysis; fMLP, N&#x02010;formyl&#x02010;methionyl&#x02010;leucyl&#x02010;phenylalanine; PD, peritoneal dialysis; PMA, Phorbol 12&#x02010;myristate 13&#x02010;acetate; <styled-content style="fixed-case" toggle="no">
<italic toggle="no">S. aureus</italic>
</styled-content>, <styled-content style="fixed-case" toggle="no">
<italic toggle="no">Staphylococcus aureus</italic>
</styled-content>; SD, standard deviation; <styled-content style="fixed-case" toggle="no">
<italic toggle="no">S. epidermidis</italic>
</styled-content>, <italic toggle="yes">Streptococcus epidermidis</italic>; TNF&#x003b1;, tumor necrosis factor &#x003b1;.</p></caption><graphic xlink:href="APHA-241-e70057-g004" position="anchor" id="jats-graphic-5"/></fig><p>We therefore subdivided the included studies depending on the absence vs. presence as well as the type of stimulus. This revealed a significantly increased ROS production in resting neutrophils from dialysis patients (of which 91% HD patients) vs. healthy controls (Figure&#x000a0;<xref rid="apha70057-fig-0004" ref-type="fig">4A</xref>; resting: Hedges <italic toggle="yes">g</italic>&#x02009;=&#x02009;1.20, 95% CI: [0.32; 2.09]). Upon neutrophil stimulation, data remained highly variable (Figure&#x000a0;<xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S4</xref>). Stimuli included both direct bacterial or fungal triggers as well as stimuli that may rather reflect sterile inflammatory conditions, being PMA and fMLP (officially called fMLF, a prototypical formyl peptide used in research, with similar formylated peptides produced by mitochondria and released upon cell injury [<xref rid="apha70057-bib-0066" ref-type="bibr">66</xref>]). When focusing specifically on these latter, neutrophils from PD patients showed an overall increased ROS production compared to healthy controls (Figure&#x000a0;<xref rid="apha70057-fig-0004" ref-type="fig">4B</xref>; PD: Hedges <italic toggle="yes">g</italic>&#x02009;=&#x02009;0.89, 95% CI: [0.34; 1.43], <italic toggle="yes">I</italic>
<sup>2</sup>&#x02009;=&#x02009;0%). In contrast, no significant effect could be observed in HD patients: ROS production upon neutrophil stimulation with PMA, fMLP, or fMLP following prior TNF&#x003b1; stimulation was identified to be significantly decreased in 7 out of 15 datasets on HD patients, though unaltered (<italic toggle="yes">n</italic>&#x02009;=&#x02009;5 datasets) or increased (<italic toggle="yes">n</italic>&#x02009;=&#x02009;3 datasets) in the remaining 8 datasets. (Figure&#x000a0;<xref rid="apha70057-fig-0004" ref-type="fig">4B</xref>; HD: Hedges <italic toggle="yes">g</italic>&#x02009;=&#x02009;&#x02212;0.58; 95% CI: [&#x02212;1.61; 0.46], <italic toggle="yes">I</italic>
<sup>2</sup>&#x02009;=&#x02009;94%).</p><fig position="float" fig-type="FIGURE" id="apha70057-fig-0004"><label>FIGURE 4</label><caption><p>Meta&#x02010;analysis of ROS production by resting or stimulated neutrophils from CKD patients on dialysis. (A) Meta&#x02010;analysis shows increased ROS production by resting neutrophils from predominantly hemodialysis&#x02010;patients versus controls. Forest plot of neutrophil ROS production in dialysis patients compared to healthy controls, with analysis of the subgroup &#x0201c;resting neutrophils&#x0201d;. Provided is a zoomed extract from the full meta&#x02010;analysis of the effect of stimulus presence and type on ROS generation in neutrophils, as displayed in Figure&#x000a0;<xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S4</xref>. (B) Meta&#x02010;analysis shows increased ROS generation in neutrophils of PD patients, when stimulated with stimuli reflecting sterile inflammatory conditions. Forest plot of neutrophil ROS production in dialysis patients compared to healthy controls upon neutrophil stimulation with fMLP, fMLP and TNF&#x003b1; or PMA. CI, confidence interval; CKD, chronic kidney disease; fMLP, N&#x02010;formyl&#x02010;methionyl&#x02010;leucyl&#x02010;phenylalanine; HD, hemodialysis; PD, peritoneal dialysis; PMA, Phorbol 12&#x02010;myristate 13&#x02010;acetate; SD, standard deviation, TNF&#x003b1;, tumor necrosis factor &#x003b1;.</p></caption><graphic xlink:href="APHA-241-e70057-g003" position="anchor" id="jats-graphic-7"/></fig><p>All combined, these meta&#x02010;analyses indicate that in basal, unstimulated conditions, ROS production is increased in neutrophils from CKD patients on HD, while CKD patients on PD are insufficiently investigated. Upon sterile inflammatory stimulation of neutrophils, ROS production is increased in CKD patients receiving PD, with findings yet inconclusive for CKD patients on HD due to high data variability (Figure&#x000a0;<xref rid="apha70057-fig-0002" ref-type="fig">2</xref>).</p></sec></sec><sec sec-type="discussion" id="apha70057-sec-0019"><label>4</label><title>Discussion</title><p>Our systematic review revealed that neutrophils from CKD patients on HD generally show reduced phagocytosis capacity (reflecting a reduced response to an acute infection) but increased neutrophil degranulation and basal ROS production (reflecting an increased basal inflammatory response) compared to healthy controls. In contrast, neutrophils from non&#x02010;dialysis&#x02010;dependent CKD patients and CKD patients on PD mostly showed unaltered phagocytosis and basal ROS production (Figure&#x000a0;<xref rid="apha70057-fig-0002" ref-type="fig">2</xref>). A meta&#x02010;analysis confirmed an increased basal ROS production in neutrophils of CKD patients on HD. Upon neutrophil stimulation with sterile inflammatory triggers, ROS production was also increased in neutrophils from PD patients.</p><p>Increased basal ROS production in resting neutrophils from HD patients points to enhanced basal cellular priming, and the procedure of HD can indeed be expected to affect neutrophil phenotype more than in the case of PD. Contributing factors include cellular stress induced by the HD procedure during which neutrophils are regularly exposed to shear stress and exogenous materials (dialysis membrane, (heparinized) plastic tubing, etc.) for a longer time. This is absent in non&#x02010;dialysis CKD patients, but also in PD patients in whom the peritoneum functions as an endogenous dialysis membrane. Other causes of HD&#x02010;induced cellular stress could be uremic retention solute accumulation in between HD procedures (with higher fluctuation in circulating levels compared to the continuous PD procedure), complement activation, chronic low&#x02010;grade inflammation [<xref rid="apha70057-bib-0067" ref-type="bibr">67</xref>, <xref rid="apha70057-bib-0068" ref-type="bibr">68</xref>] or iron overload [<xref rid="apha70057-bib-0020" ref-type="bibr">20</xref>, <xref rid="apha70057-bib-0024" ref-type="bibr">24</xref>], amongst others. The high variability in neutrophil readouts (including also apoptosis, surface activation markers, NET formation and phagocytosis) observed in HD patients may be due to differences in dialysis membranes [<xref rid="apha70057-bib-0040" ref-type="bibr">40</xref>] and modalities used, which may trigger alterations in uremic retention solute removal or dialysis&#x02010;induced inflammatory reactions and cellular stress. In line, a transient increase in neutrophil activation markers during the HD procedure has been observed dependent on the dialysis membrane used [<xref rid="apha70057-bib-0052" ref-type="bibr">52</xref>].</p><p>Neutrophil priming and increased basal ROS levels could also explain a secondary functional impairment with a reduced fold&#x02010;change upregulation of ROS production upon neutrophil stimulation (which has been described for NET formation in HD patient&#x02010;derived neutrophils [<xref rid="apha70057-bib-0022" ref-type="bibr">22</xref>]) or even reduced ROS production by stimulated neutrophils in HD patients [<xref rid="apha70057-bib-0031" ref-type="bibr">31</xref>] (Table&#x000a0;<xref rid="apha70057-tbl-0001" ref-type="table">1</xref>, Figure&#x000a0;<xref rid="apha70057-fig-0004" ref-type="fig">4B</xref>). This supports the hypothesis that neutrophils of HD patients may already be in a primed state due to the uremic and/or inflammatory milieu they are consistently exposed to, an effect that could be mimicked when incubating neutrophils from healthy individuals in plasma from HD patients [<xref rid="apha70057-bib-0031" ref-type="bibr">31</xref>].</p><p>On the other hand, basal cellular priming can also trigger increased secondary responses (&#x0201c;positive priming&#x0201d;), with multiple studies on neutrophils in HD patients also reporting on increased stimulation&#x02010;induced ROS production (Table&#x000a0;<xref rid="apha70057-tbl-0001" ref-type="table">1</xref>, Figure&#x000a0;<xref rid="apha70057-fig-0004" ref-type="fig">4B</xref>). However, in these studies, the results were dependent on the stimulus used (Figure&#x000a0;<xref rid="apha70057-fig-0004" ref-type="fig">4A</xref>, Table&#x000a0;<xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S8</xref>) [<xref rid="apha70057-bib-0013" ref-type="bibr">13</xref>, <xref rid="apha70057-bib-0020" ref-type="bibr">20</xref>, <xref rid="apha70057-bib-0028" ref-type="bibr">28</xref>, <xref rid="apha70057-bib-0031" ref-type="bibr">31</xref>]. For example, Sela et&#x000a0;al. found an increase in ROS production upon stimulation of HD patient&#x02010;derived neutrophils with PMA (mimicking sterile inflammation) but a decrease with Zymosan (a component of the cell wall of yeast, mimicking microbial infection) [<xref rid="apha70057-bib-0013" ref-type="bibr">13</xref>]. The latter may be linked to the high susceptibility of CKD patients to acute infection [<xref rid="apha70057-bib-0069" ref-type="bibr">69</xref>, <xref rid="apha70057-bib-0070" ref-type="bibr">70</xref>].</p><p>The overall high variability in findings on neutrophil activity readouts in CKD between different studies could be due to a high patient population heterogeneity with regard to CKD stage, primary underlying CKD pathology, existing comorbidities such as hypertension, obesity, diabetes, and CVD [<xref rid="apha70057-bib-0008" ref-type="bibr">8</xref>], as well as medication. For example, diabetes&#x02014;a known cause and promoter of inflammation and oxidative stress [<xref rid="apha70057-bib-0071" ref-type="bibr">71</xref>], neutrophil activation [<xref rid="apha70057-bib-0072" ref-type="bibr">72</xref>] as well as of CKD [<xref rid="apha70057-bib-0008" ref-type="bibr">8</xref>]&#x02014;was an exclusion criterium in only 17% of the included studies and could well be a variable factor between different studies of CKD patients. Towards the use of immunosuppressants, six of the 18 studies included in the meta&#x02010;analysis explicitly excluded patients on immunosuppressive therapy, and another two excluded patients with immunological disorders or with diseases associated with neutrophil dysfunction. Moreover, the dialysis type, duration on dialysis [<xref rid="apha70057-bib-0073" ref-type="bibr">73</xref>], and for HD patients also the timing of neutrophil analysis in relation to dialysis application and the applied dialysis membrane (which varied throughout the studies included in the meta&#x02010;analysis) may contribute to the high interstudy data heterogeneity in the meta&#x02010;analysis.</p><p>Also, the methods for analyzing ROS levels in neutrophils varied throughout the included papers, both in terms of analyzing extracellular vs. intracellular ROS (or a combination of both), as well as in terms of the specific assay used and ROS type measured. Neutrophils mainly produce ROS via the NADPH oxidase (NOX2), which reduces oxygen to the superoxide radical (O<sub>2</sub>
<sup>&#x02022;&#x02010;</sup>). Superoxide can either be produced at the plasma membrane (extracellular ROS) or in intracellular compartments (intracellular ROS) [<xref rid="apha70057-bib-0014" ref-type="bibr">14</xref>]. Superoxide rapidly dismutates to hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) by superoxide dismutase (SOD) or spontaneously, and can also convert to other types of ROS (e.g., peroxynitrite (ONOO<sup>&#x02212;</sup>)). PMA is a potent inducer of both intra&#x02010; and extracellular ROS production. The produced ROS is subsequently important for neutrophil function. For example, NADPH&#x02010;oxidase&#x02010;dependent intracellular ROS production is important for the killing capacity of neutrophils towards microbes, as well as for PMA&#x02010;induced NETosis [<xref rid="apha70057-bib-0014" ref-type="bibr">14</xref>]. In the meta&#x02010;analysis, 9 of 18 studies are based on the detection of superoxide. With superoxide rapidly converting to peroxynitrite or H<sub>2</sub>O<sub>2</sub>, measuring superoxide is a more unreliable ROS detection method compared to H<sub>2</sub>O<sub>2</sub>, which is less reactive. Overall, the use of chemical probes to measure ROS has several pitfalls, as extensively discussed before [<xref rid="apha70057-bib-0074" ref-type="bibr">74</xref>, <xref rid="apha70057-bib-0075" ref-type="bibr">75</xref>]. Briefly, lack of specificity, no subcellular localization, indirect mechanism of oxidation, photo&#x02010;oxidation, and the fact that these probes are prone to artifacts are amongst the main problems (Table&#x000a0;<xref rid="apha70057-supitem-0001" ref-type="supplementary-material">S9</xref>). For example, probes such as dihydrorhodamine also react with reactive nitrogen species. It is also important to mention that ROS production and removal are highly compartmentalized reactions and are unlikely to have effects far from the site where they are generated [<xref rid="apha70057-bib-0076" ref-type="bibr">76</xref>]. Understanding these limitations helps to interpret the great variability in some of the conditions discussed above. Of note, a lack of ROS changes in some conditions does not necessarily mean that ROS do not play an important role in CKD. It would be interesting to analyze specific ROS at defined cellular compartments to understand the causal role of different redox systems in CKD (e.g., mitochondria versus NADPH oxidase). Finally, ROS are important signaling molecules; therefore, understanding what the &#x0201c;optimal&#x0201d; ROS levels for cellular function are and when this threshold is shifted towards pathophysiology is still a highly active field of research [<xref rid="apha70057-bib-0077" ref-type="bibr">77</xref>].</p><p>Circulating blood neutrophils exhibit a remarkable heterogeneity. At any given time, various phenotypes of neutrophils coexist, with young vs. aged neutrophils representing a classic example of phenotypic heterogeneity at steady state. In disease states, such heterogeneity becomes more complex as discrete phenotypes of activated, primed, and immature neutrophils appear [<xref rid="apha70057-bib-0078" ref-type="bibr">78</xref>, <xref rid="apha70057-bib-0079" ref-type="bibr">79</xref>]. Yet, these states are not just phenotypes discernable by surface markers, but indeed exhibit differential responses in terms of NET release, phagocytosis, adhesion, and ROS production. Thus, analyses based on assessing neutrophil functionality on a bulk scale may not suffice to identify altered responsiveness of neutrophil phenotypes. As an example, ROS production is often assessed in plate reader assays where a signal is recorded over time and possibly normalized by the number of cells seeded. Such population&#x02010;based analysis disregards differential responses of subpopulations, information only single cell&#x02010;based assays can reveal. Thus, flow cytometry&#x02010;based analysis of ROS production in different activation and maturation stages of neutrophils would yield more robust and detailed information of neutrophil responses. In addition to subset&#x02010;specific responses, methods of neutrophil extraction have tremendous effects on neutrophil responses. Lysis of red blood cells, density gradient centrifugation, and temperature changes all impact the phenotypic appearance of neutrophils and functionality, and different isolation protocols across studies assessed here may at least in part explain data heterogeneity. Moreover, the isolation protocol may even get rid of certain neutrophil subsets. As an example, low&#x02010;density granulocytes are found in the PBMC fraction rather than in the neutrophil fraction in density gradient&#x02010;based isolation procedures. Finally, and in addition to what has been described above for ROS production, it is key to provide details on experimental procedures. Phagocytosis assays, for example, are often performed with bacteria&#x02010;based bioparticles. As a considerable number of these bioparticles are only bound to neutrophil surfaces and not internalized, newer versions of these bioparticles are conjugated with a pH&#x02010;sensitive dye allowing for the recording of the acidification in the phagolysosome. Yet, in the body, bacteria are always opsonized either with antibodies or with activated complement, reagents often not used in ex&#x000a0;vivo phagocytosis assays. Thus, the use of different opsonins and consequently different phagocytosis pathways may explain part of the data heterogeneity observed here.</p><p>A limitation of our study is the large time span between the included studies, ranging from 1990 until 2023. This may have impacted disease management (and thus characteristics of patients and their neutrophils), dialysis methods as well as research methods (e.g., differences in neutrophil isolation, different method of ROS analysis). Furthermore, non&#x02010;dialysis dependent CKD patients were not further specified according to CKD stage. Finally, we classified the presence of different neutrophil granule markers and histone&#x02010;DNA in blood as parameters for &#x0201c;degranulation&#x0201d;. However, these are not necessarily related to degranulation or even secretion but could also result from neutrophil death or from other cell types (as e.g., MPO from monocytes).</p></sec><sec sec-type="conclusions" id="apha70057-sec-0020"><label>5</label><title>Conclusions</title><p>In conclusion, our study identified reduced phagocytic capacity but increased degranulation and basal ROS production in neutrophils from CKD patients on HD. This reflects a chronic inflammatory response but reduced responsiveness of neutrophils to an acute infection. Instead, increased basal ROS and reduced phagocytosis were mostly not detected in CKD patients on PD or non&#x02010;dialysis&#x02010;dependent CKD patients. Nonetheless, caution remains required since in general only a limited number of studies have addressed these patient groups, and additional studies on surface markers, NET formation, and degranulation markers are needed. A more detailed and side&#x02010;by&#x02010;side comparison of patients in stages CKD2&#x02013;4 for different readouts of neutrophil function as well as studying neutrophil function in patients with CKD in relation to comorbidities (as diabetes) may provide further insight into the inherent effect of CKD on neutrophil activity.</p><p>We suggest future studies assessing the detailed neutrophil phenotype to combine the analysis of different activation markers on the neutrophil surface in whole blood, a fluorescent&#x02010;based phagocytosis bead assay as well as an assay for NET formation on isolated neutrophils. Analysis is recommended in both basal conditions as well as upon activation with different stimuli, such as PMA vs. IL8 or fMLP, since different signaling mechanisms may be differentially affected by the underlying pathology. Although PMA is a frequently applied stimulus, it is a synthetic stimulus that directly activates protein kinase C without the aid of any membrane receptor. When analyzing ROS, a flow cytometry&#x02010;based assay has the advantage to focus on neutrophils in a whole blood setting and to analyze the readout per cell. Analyzing mitochondrial versus NADPH&#x02010;oxidase would be interesting, and given the inherent difficulties with ROS assays described above, a combination of different assays with appropriate controls is advisable. Depending on the research question, exclusion of patients on immunosuppressive therapy is recommended, and patient characteristics and clinical details (including age, sex, CKD stage, comorbidities and medication, time on dialysis and time of blood sampling relative to the dialysis sessions) should be reported.</p><p>To our knowledge, no specific outcome studies investigating the association of markers of increased neutrophil activity to cardiovascular outcome have been performed in CKD patients so far, although this would be of high clinical relevance. Patients with CKD have an increased cardiovascular risk, to which increased neutrophil activation, ROS production, and NET formation [<xref rid="apha70057-bib-0010" ref-type="bibr">10</xref>] but also altered neutrophil interactions with endothelium [<xref rid="apha70057-bib-0080" ref-type="bibr">80</xref>] and platelets may contribute. Thus, a further clarification of the impact of CKD on these neutrophil responses also in CKD2&#x02010;4 could support future management of chronic inflammation and cardiovascular risk in CKD patients.</p></sec><sec id="apha70057-sec-0025"><title>Author Contributions</title><p>
<bold>Jane Sophie Lauxen:</bold> investigation, data curation, formal analysis, visualization, writing &#x02013; original draft, writing &#x02013; review and editing. <bold>Sonja Vondenhoff:</bold> validation, writing &#x02013; review and editing. <bold>Carolina Victoria Cruz Junho:</bold> investigation, validation, writing &#x02013; review and editing. <bold>Philipp Martin:</bold> validation, writing &#x02013; review and editing. <bold>Susanne Fleig:</bold> writing &#x02013; review and editing. <bold>Katharina Sch&#x000fc;tt:</bold> writing &#x02013; review and editing. <bold>Ulrike Schulze&#x02010;Sp&#x000e4;te:</bold> writing &#x02013; review and editing. <bold>Oliver Soehnlein:</bold> writing &#x02013; review and editing. <bold>Leticia Prates&#x02010;Roma:</bold> writing &#x02013; review and editing. <bold>Yvonne D&#x000f6;ring:</bold> writing &#x02013; review and editing. <bold>Constance C. F. M. J. Baaten:</bold> methodology, software, visualization, writing &#x02013; review and editing. <bold>Heidi Noels:</bold> conceptualization, funding acquisition, methodology, supervision, validation, writing &#x02013; review and editing.</p></sec><sec sec-type="COI-statement" id="apha70057-sec-0021"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="apha70057-supitem-0001" position="float" content-type="local-data"><caption><p>
<bold>Data S1.</bold> supporting Information.</p></caption><media xlink:href="APHA-241-e70057-s001.pdf"/></supplementary-material></sec></body><back><ack id="apha70057-sec-0022"><title>Acknowledgments</title><p>We thank Prof. Dr. Raymond Vanholder for a critical evaluation and constructive feedback to this manuscript. Open Access funding enabled and organized by Projekt DEAL.</p></ack><sec sec-type="data-availability" id="apha70057-sec-0024"><title>Data Availability Statement</title><p>Data extracted from the included studies and used for all analyses are presented in detail in Table&#x000a0;<xref rid="apha70057-tbl-0002" ref-type="table">2</xref> and the meta&#x02010;analysis figures. The extracted data values used in the meta&#x02010;analysis are also publicly available as Supplemental Data Set via the University library of the RWTH Aachen (DOI: <ext-link xlink:href="https://doi.org/10.18154/RWTH-2025-03170" ext-link-type="uri" specific-use="dataset is-supplemented-by">https://doi.org/10.18154/RWTH&#x02010;2025&#x02010;03170</ext-link>).</p></sec><ref-list content-type="cited-references" id="apha70057-bibl-0001"><title>References</title><ref id="apha70057-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="apha70057-cit-0001">
<string-name>
<given-names>A.</given-names>
<surname>Francis</surname>
</string-name>, <string-name>
<given-names>M. N.</given-names>
<surname>Harhay</surname>
</string-name>, <string-name>
<given-names>A. C. M.</given-names>
<surname>Ong</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Chronic Kidney Disease and the Global Public Health Agenda: An International Consensus</article-title>,&#x0201d; <source>Nature Reviews. Nephrology</source>
<volume>20</volume> (<year>2024</year>): <fpage>473</fpage>&#x02013;<lpage>485</lpage>, <pub-id pub-id-type="doi">10.1038/s41581-024-00820-6</pub-id>.<pub-id pub-id-type="pmid">38570631</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="apha70057-cit-0002">
<string-name>
<given-names>N. R.</given-names>
<surname>Hill</surname>
</string-name>, <string-name>
<given-names>S. T.</given-names>
<surname>Fatoba</surname>
</string-name>, <string-name>
<given-names>J. L.</given-names>
<surname>Oke</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Global Prevalence of Chronic Kidney Disease&#x02014;A Systematic Review and Meta&#x02010;Analysis</article-title>,&#x0201d; <source>PLoS One</source>
<volume>11</volume>, no. <issue>7</issue> (<year>2016</year>): <elocation-id>e0158765</elocation-id>, <pub-id pub-id-type="doi">10.1371/journal.pone.0158765</pub-id>.<pub-id pub-id-type="pmid">27383068</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="apha70057-cit-0003">
<string-name>
<given-names>L. A.</given-names>
<surname>Inker</surname>
</string-name>, <string-name>
<given-names>B. C.</given-names>
<surname>Astor</surname>
</string-name>, <string-name>
<given-names>C. H.</given-names>
<surname>Fox</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD</article-title>,&#x0201d; <source>American Journal of Kidney Diseases</source>
<volume>63</volume> (<year>2014</year>): <fpage>713</fpage>&#x02013;<lpage>735</lpage>, <pub-id pub-id-type="doi">10.1053/j.ajkd.2014.01.416</pub-id>.<pub-id pub-id-type="pmid">24647050</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="apha70057-cit-0004">
<string-name>
<given-names>K.</given-names>
<surname>Matsushita</surname>
</string-name>, <string-name>
<given-names>S. H.</given-names>
<surname>Ballew</surname>
</string-name>, <string-name>
<given-names>A. Y.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Kalyesubula</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Schaeffner</surname>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Agarwal</surname>
</string-name>, &#x0201c;<article-title>Epidemiology and Risk of Cardiovascular Disease in Populations With Chronic Kidney Disease</article-title>,&#x0201d; <source>Nature Reviews. Nephrology</source>
<volume>18</volume> (<year>2022</year>): <fpage>696</fpage>&#x02013;<lpage>707</lpage>, <pub-id pub-id-type="doi">10.1038/s41581-022-00616-6</pub-id>.<pub-id pub-id-type="pmid">36104509</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="apha70057-cit-0005">
<string-name>
<given-names>C.</given-names>
<surname>Zoccali</surname>
</string-name> and <string-name>
<given-names>F.</given-names>
<surname>Mallamaci</surname>
</string-name>, &#x0201c;<article-title>Innate Immunity System in Patients With Cardiovascular and Kidney Disease</article-title>,&#x0201d; <source>Circulation Research</source>
<volume>132</volume> (<year>2023</year>): <fpage>915</fpage>&#x02013;<lpage>932</lpage>, <pub-id pub-id-type="doi">10.1161/circresaha.122.321749</pub-id>.<pub-id pub-id-type="pmid">37053283</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="apha70057-cit-0006">
<string-name>
<given-names>S.</given-names>
<surname>Thompson</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>James</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Wiebe</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Cause of Death in Patients With Reduced Kidney Function</article-title>,&#x0201d; <source>Journal of the American Society of Nephrology</source>
<volume>26</volume> (<year>2015</year>): <fpage>2504</fpage>&#x02013;<lpage>2511</lpage>, <pub-id pub-id-type="doi">10.1681/asn.2014070714</pub-id>.<pub-id pub-id-type="pmid">25733525</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="apha70057-cit-0007">
<string-name>
<given-names>J. M.</given-names>
<surname>Valdivielso</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Rodriguez&#x02010;Puyol</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Pascual</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Atherosclerosis in Chronic Kidney Disease: More, Less, or Just Different?</article-title>,&#x0201d; <source>Arteriosclerosis, Thrombosis, and Vascular Biology</source>
<volume>39</volume> (<year>2019</year>): <fpage>1938</fpage>&#x02013;<lpage>1966</lpage>, <pub-id pub-id-type="doi">10.1161/ATVBAHA.119.312705</pub-id>.<pub-id pub-id-type="pmid">31412740</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="apha70057-cit-0008">
<string-name>
<given-names>J.</given-names>
<surname>Jankowski</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Floege</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Fliser</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Bohm</surname>
</string-name>, and <string-name>
<given-names>N.</given-names>
<surname>Marx</surname>
</string-name>, &#x0201c;<article-title>Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options</article-title>,&#x0201d; <source>Circulation</source>
<volume>143</volume> (<year>2021</year>): <fpage>1157</fpage>&#x02013;<lpage>1172</lpage>, <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.120.050686</pub-id>.<pub-id pub-id-type="pmid">33720773</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="apha70057-cit-0009">
<string-name>
<given-names>H.</given-names>
<surname>Noels</surname>
</string-name> and <string-name>
<given-names>J.</given-names>
<surname>Jankowski</surname>
</string-name>, &#x0201c;<article-title>Increased Risk of Cardiovascular Complications in Chronic Kidney Disease: Introduction to a Compendium</article-title>,&#x0201d; <source>Circulation Research</source>
<volume>132</volume> (<year>2023</year>): <fpage>899</fpage>&#x02013;<lpage>901</lpage>, <pub-id pub-id-type="doi">10.1161/circresaha.123.322806</pub-id>.<pub-id pub-id-type="pmid">37053281</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="apha70057-cit-0010">
<string-name>
<given-names>M.</given-names>
<surname>Thakur</surname>
</string-name>, <string-name>
<given-names>C. V. C.</given-names>
<surname>Junho</surname>
</string-name>, <string-name>
<given-names>S. M.</given-names>
<surname>Bernhard</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Schindewolf</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Noels</surname>
</string-name>, and <string-name>
<given-names>Y.</given-names>
<surname>D&#x000f6;ring</surname>
</string-name>, &#x0201c;<article-title>NETs&#x02010;Induced Thrombosis Impacts on Cardiovascular and Chronic Kidney Disease</article-title>,&#x0201d; <source>Circulation Research</source>
<volume>132</volume> (<year>2023</year>): <fpage>933</fpage>&#x02013;<lpage>949</lpage>, <pub-id pub-id-type="doi">10.1161/circresaha.123.321750</pub-id>.<pub-id pub-id-type="pmid">37053273</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="apha70057-cit-0011">
<string-name>
<given-names>C.</given-names>
<surname>Silvestre&#x02010;Roig</surname>
</string-name>, <string-name>
<given-names>Q.</given-names>
<surname>Braster</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Ortega&#x02010;Gomez</surname>
</string-name>, and <string-name>
<given-names>O.</given-names>
<surname>Soehnlein</surname>
</string-name>, &#x0201c;<article-title>Neutrophils as Regulators of Cardiovascular Inflammation</article-title>,&#x0201d; <source>Nature Reviews. Cardiology</source>
<volume>17</volume> (<year>2020</year>): <fpage>327</fpage>&#x02013;<lpage>340</lpage>, <pub-id pub-id-type="doi">10.1038/s41569-019-0326-7</pub-id>.<pub-id pub-id-type="pmid">31996800</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="apha70057-cit-0012">
<string-name>
<given-names>C. H.</given-names>
<surname>Yen</surname>
</string-name>, <string-name>
<given-names>I. W.</given-names>
<surname>Wu</surname>
</string-name>, <string-name>
<given-names>C. C.</given-names>
<surname>Lee</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>The Prognostic Value of Peripheral Total and Differential Leukocyte Count in Renal Progression: A Community&#x02010;Based Study</article-title>,&#x0201d; <source>PLoS One</source>
<volume>16</volume> (<year>2021</year>): <elocation-id>e0258210</elocation-id>, <pub-id pub-id-type="doi">10.1371/journal.pone.0258210</pub-id>.<pub-id pub-id-type="pmid">34710093</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="apha70057-cit-0013">
<string-name>
<given-names>S.</given-names>
<surname>Sela</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Shurtz&#x02010;Swirski</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Cohen&#x02010;Mazor</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Primed Peripheral Polymorphonuclear Leukocyte: A Culprit Underlying Chronic Low&#x02010;Grade Inflammation and Systemic Oxidative Stress in Chronic Kidney Disease</article-title>,&#x0201d; <source>Journal of the American Society of Nephrology</source>
<volume>16</volume> (<year>2005</year>): <fpage>2431</fpage>&#x02013;<lpage>2438</lpage>, <pub-id pub-id-type="doi">10.1681/asn.2004110929</pub-id>.<pub-id pub-id-type="pmid">15987755</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="apha70057-cit-0014">
<string-name>
<given-names>C.</given-names>
<surname>Dahlgren</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Karlsson</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Bylund</surname>
</string-name>, &#x0201c;<article-title>Intracellular Neutrophil Oxidants: From Laboratory Curiosity to Clinical Reality</article-title>,&#x0201d; <source>Journal of Immunology</source>
<volume>202</volume> (<year>2019</year>): <fpage>3127</fpage>&#x02013;<lpage>3134</lpage>, <pub-id pub-id-type="doi">10.4049/jimmunol.1900235</pub-id>.</mixed-citation></ref><ref id="apha70057-bib-0015"><label>15</label><mixed-citation publication-type="miscellaneous" id="apha70057-cit-0015">
<collab collab-type="authors">Team R</collab>
, <article-title>&#x0201c;RStudio: Integrated Development for R,&#x0201d;</article-title>
<year>2016</year>, accessed October 6, <ext-link xlink:href="https://www.rstudio.com" ext-link-type="uri">https://www.rstudio.com</ext-link>.</mixed-citation></ref><ref id="apha70057-bib-0016"><label>16</label><mixed-citation publication-type="miscellaneous" id="apha70057-cit-0016">
<string-name>
<given-names>M.</given-names>
<surname>Harrer</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Cuijpers</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Furukawa</surname>
</string-name>, and <string-name>
<given-names>D. D.</given-names>
<surname>Ebert</surname>
</string-name>, <article-title>&#x0201c;dmetar: Companion R package for the guide &#x02018;Doing Meta&#x02010;Analysis in R&#x02019;,&#x0201d;</article-title>
<year>2019</year>, accessed January 21, <ext-link xlink:href="https://dmetar.protectlab.org/" ext-link-type="uri">https://dmetar.protectlab.org/</ext-link>.</mixed-citation></ref><ref id="apha70057-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="apha70057-cit-0017">
<string-name>
<given-names>G.</given-names>
<surname>Cohen</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Raupachova</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Ilic</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Werzowa</surname>
</string-name>, and <string-name>
<given-names>W. H.</given-names>
<surname>H&#x000f6;rl</surname>
</string-name>, &#x0201c;<article-title>Effect of Leptin on Polymorphonuclear Leucocyte Functions in Healthy Subjects and Haemodialysis Patients</article-title>,&#x0201d; <source>Nephrology, Dialysis, Transplantation</source>
<volume>26</volume> (<year>2011</year>): <fpage>2271</fpage>&#x02013;<lpage>2281</lpage>, <pub-id pub-id-type="doi">10.1093/ndt/gfq731</pub-id>.</mixed-citation></ref><ref id="apha70057-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="apha70057-cit-0018">
<string-name>
<given-names>M.</given-names>
<surname>Cohen&#x02010;Mazor</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Sela</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Mazor</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Are Primed Polymorphonuclear Leukocytes Contributors to the High Heparanase Levels in Hemodialysis Patients?</article-title>,&#x0201d; <source>American Journal of Physiology. Heart and Circulatory Physiology</source>
<volume>294</volume> (<year>2008</year>): <fpage>H651</fpage>&#x02013;<lpage>H658</lpage>, <pub-id pub-id-type="doi">10.1152/ajpheart.00952.2007</pub-id>.<pub-id pub-id-type="pmid">18032524</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="apha70057-cit-0019">
<string-name>
<given-names>K.</given-names>
<surname>Cohen&#x02010;Hagai</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Nacasch</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Sternschuss</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Malnutrition and Inflammation in Hemodialysis Patients: Comparative Evaluation of Neutrophil Reactive Oxygen Formation</article-title>,&#x0201d; <source>Nutrition</source>
<volume>78</volume> (<year>2020</year>): <elocation-id>110793</elocation-id>, <pub-id pub-id-type="doi">10.1016/j.nut.2020.110793</pub-id>.<pub-id pub-id-type="pmid">32454385</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="apha70057-cit-0020">
<string-name>
<given-names>D.</given-names>
<surname>Guo</surname>
</string-name>, <string-name>
<given-names>B. L.</given-names>
<surname>Jaber</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Lee</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Impact of Iron Dextran on Polymorphonuclear Cell Function Among Hemodialysis Patients</article-title>,&#x0201d; <source>Clinical Nephrology</source>
<volume>58</volume> (<year>2002</year>): <fpage>134</fpage>&#x02013;<lpage>142</lpage>, <pub-id pub-id-type="doi">10.5414/cnp58134</pub-id>.<pub-id pub-id-type="pmid">12227686</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="apha70057-cit-0021">
<string-name>
<given-names>A. P.</given-names>
<surname>Haynes</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Daniels</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Porter</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Fletcher</surname>
</string-name>, and <string-name>
<given-names>A. G.</given-names>
<surname>Morgan</surname>
</string-name>, &#x0201c;<article-title>Abnormal Cytoplasmic pH Regulation During Activation in Uremic Neutrophils</article-title>,&#x0201d; <source>Kidney International</source>
<volume>42</volume> (<year>1992</year>): <fpage>690</fpage>&#x02013;<lpage>699</lpage>, <pub-id pub-id-type="doi">10.1038/ki.1992.336</pub-id>.<pub-id pub-id-type="pmid">1328756</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="apha70057-cit-0022">
<string-name>
<given-names>J. K.</given-names>
<surname>Kim</surname>
</string-name>, <string-name>
<given-names>C. W.</given-names>
<surname>Hong</surname>
</string-name>, <string-name>
<given-names>M. J.</given-names>
<surname>Park</surname>
</string-name>, <string-name>
<given-names>Y. R.</given-names>
<surname>Song</surname>
</string-name>, <string-name>
<given-names>H. J.</given-names>
<surname>Kim</surname>
</string-name>, and <string-name>
<given-names>S. G.</given-names>
<surname>Kim</surname>
</string-name>, &#x0201c;<article-title>Increased Neutrophil Extracellular Trap Formation in Uremia Is Associated With Chronic Inflammation and Prevalent Coronary Artery Disease</article-title>,&#x0201d; <source>Journal of Immunological Research</source>
<volume>2017</volume> (<year>2017</year>): <elocation-id>8415179</elocation-id>, <pub-id pub-id-type="doi">10.1155/2017/8415179</pub-id>.</mixed-citation></ref><ref id="apha70057-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="apha70057-cit-0023">
<string-name>
<given-names>B.</given-names>
<surname>Kristal</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Shurtz&#x02010;Swirski</surname>
</string-name>, <string-name>
<given-names>S. M.</given-names>
<surname>Shasha</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Interaction Between Erythropoietin and Peripheral Polymorphonuclear Leukocytes in Hemodialysis Patients</article-title>,&#x0201d; <source>Nephron</source>
<volume>81</volume> (<year>1999</year>): <fpage>406</fpage>&#x02013;<lpage>413</lpage>, <pub-id pub-id-type="doi">10.1159/000045324</pub-id>.<pub-id pub-id-type="pmid">10095176</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="apha70057-cit-0024">
<string-name>
<given-names>Y.</given-names>
<surname>Otaki</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Nakanishi</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Hasuike</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Defective Regulation of Iron Transporters Leading to Iron Excess in the Polymorphonuclear Leukocytes of Patients on Maintenance Hemodialysis</article-title>,&#x0201d; <source>American Journal of Kidney Diseases</source>
<volume>43</volume> (<year>2004</year>): <fpage>1030</fpage>&#x02013;<lpage>1039</lpage>, <pub-id pub-id-type="doi">10.1053/j.ajkd.2004.02.016</pub-id>.<pub-id pub-id-type="pmid">15168383</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="apha70057-cit-0025">
<string-name>
<given-names>S. I.</given-names>
<surname>Patruta</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Edlinger</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Sunder&#x02010;Plassmann</surname>
</string-name>, and <string-name>
<given-names>W. H.</given-names>
<surname>H&#x000f6;rl</surname>
</string-name>, &#x0201c;<article-title>Neutrophil Impairment Associated With Iron Therapy in Hemodialysis Patients With Functional Iron Deficiency</article-title>,&#x0201d; <source>Journal of the American Society of Nephrology</source>
<volume>9</volume> (<year>1998</year>): <fpage>655</fpage>&#x02013;<lpage>663</lpage>, <pub-id pub-id-type="doi">10.1681/asn.V94655</pub-id>.<pub-id pub-id-type="pmid">9555668</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="apha70057-cit-0026">
<string-name>
<given-names>M. C.</given-names>
<surname>Perianayagam</surname>
</string-name>, <string-name>
<given-names>V. S.</given-names>
<surname>Balakrishnan</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Guo</surname>
</string-name>, <string-name>
<given-names>B. J.</given-names>
<surname>Pereira</surname>
</string-name>, and <string-name>
<given-names>B. L.</given-names>
<surname>Jaber</surname>
</string-name>, &#x0201c;<article-title>Quantification of Bax and Bcl2 in Polymorphonuclear Leukocytes From Haemodialysis Patients: Relation to Hydrogen Peroxide</article-title>,&#x0201d; <source>European Journal of Clinical Investigation</source>
<volume>33</volume> (<year>2003</year>): <fpage>905</fpage>&#x02013;<lpage>911</lpage>, <pub-id pub-id-type="doi">10.1046/j.1365-2362.2003.01225.x</pub-id>.<pub-id pub-id-type="pmid">14511363</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="apha70057-cit-0027">
<string-name>
<given-names>C. J.</given-names>
<surname>Porter</surname>
</string-name>, <string-name>
<given-names>R. P.</given-names>
<surname>Burden</surname>
</string-name>, <string-name>
<given-names>A. G.</given-names>
<surname>Morgan</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Daniels</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Fletcher</surname>
</string-name>, &#x0201c;<article-title>Impaired Bacterial Killing and Hydrogen Peroxide Production by Polymorphonuclear Neutrophils in End&#x02010;Stage Renal Failure</article-title>,&#x0201d; <source>Nephron</source>
<volume>77</volume> (<year>1997</year>): <fpage>479</fpage>&#x02013;<lpage>481</lpage>, <pub-id pub-id-type="doi">10.1159/000190328</pub-id>.<pub-id pub-id-type="pmid">9434073</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="apha70057-cit-0028">
<string-name>
<given-names>M.</given-names>
<surname>Rao</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Guo</surname>
</string-name>, <string-name>
<given-names>B. L.</given-names>
<surname>Jaber</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Dialyzer Membrane Type and Reuse Practice Influence Polymorphonuclear Leukocyte Function in Hemodialysis Patients</article-title>,&#x0201d; <source>Kidney International</source>
<volume>65</volume> (<year>2004</year>): <fpage>682</fpage>&#x02013;<lpage>691</lpage>, <pub-id pub-id-type="doi">10.1111/j.1523-1755.2004.00429.x</pub-id>.<pub-id pub-id-type="pmid">14717942</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="apha70057-cit-0029">
<string-name>
<given-names>C.</given-names>
<surname>Sardenberg</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Suassuna</surname>
</string-name>, <string-name>
<given-names>M. C.</given-names>
<surname>Andreoli</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Effects of Uraemia and Dialysis Modality on Polymorphonuclear Cell Apoptosis and Function</article-title>,&#x0201d; <source>Nephrology, Dialysis, Transplantation</source>
<volume>21</volume> (<year>2006</year>): <fpage>160</fpage>&#x02013;<lpage>165</lpage>, <pub-id pub-id-type="doi">10.1093/ndt/gfi095</pub-id>.</mixed-citation></ref><ref id="apha70057-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="apha70057-cit-0030">
<string-name>
<given-names>S.</given-names>
<surname>Talal</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Mona</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Karem</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Neutrophil Degranulation and Severely Impaired Extracellular Trap Formation at the Basis of Susceptibility to Infections of Hemodialysis Patients</article-title>,&#x0201d; <source>BMC Medicine</source>
<volume>20</volume> (<year>2022</year>): <fpage>364</fpage>, <pub-id pub-id-type="doi">10.1186/s12916-022-02564-1</pub-id>.<pub-id pub-id-type="pmid">36284314</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="apha70057-cit-0031">
<string-name>
<given-names>R.</given-names>
<surname>Ward</surname>
</string-name> and <string-name>
<given-names>K. R.</given-names>
<surname>McLeish</surname>
</string-name>, &#x0201c;<article-title>Soluble TNF Alpha Receptors Are Increased in Chronic Renal Insufficiency and Hemodialysis and Inhibit Neutrophil Priming by TNF Alpha</article-title>,&#x0201d; <source>Artificial Organs</source>
<volume>20</volume> (<year>1996</year>): <fpage>390</fpage>&#x02013;<lpage>395</lpage>, <pub-id pub-id-type="doi">10.1111/j.1525-1594.1996.tb04521.x</pub-id>.<pub-id pub-id-type="pmid">8725616</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="apha70057-cit-0032">
<string-name>
<given-names>R. A.</given-names>
<surname>Ward</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Ouseph</surname>
</string-name>, and <string-name>
<given-names>K. R.</given-names>
<surname>McLeish</surname>
</string-name>, &#x0201c;<article-title>Effects of High&#x02010;Flux Hemodialysis on Oxidant Stress</article-title>,&#x0201d; <source>Kidney International</source>
<volume>63</volume> (<year>2003</year>): <fpage>353</fpage>&#x02013;<lpage>359</lpage>, <pub-id pub-id-type="doi">10.1046/j.1523-1755.2003.00741.x</pub-id>.<pub-id pub-id-type="pmid">12472803</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="apha70057-cit-0033">
<string-name>
<given-names>J. W.</given-names>
<surname>Yoon</surname>
</string-name>, <string-name>
<given-names>M. V.</given-names>
<surname>Pahl</surname>
</string-name>, and <string-name>
<given-names>N. D.</given-names>
<surname>Vaziri</surname>
</string-name>, &#x0201c;<article-title>Spontaneous Leukocyte Activation and Oxygen&#x02010;Free Radical Generation in End&#x02010;Stage Renal Disease</article-title>,&#x0201d; <source>Kidney International</source>
<volume>71</volume> (<year>2007</year>): <fpage>167</fpage>&#x02013;<lpage>172</lpage>, <pub-id pub-id-type="doi">10.1038/sj.ki.5002019</pub-id>.<pub-id pub-id-type="pmid">17136029</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="apha70057-cit-0034">
<string-name>
<given-names>S.</given-names>
<surname>Lemesch</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Ribitsch</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Schilcher</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Mode of Renal Replacement Therapy Determines Endotoxemia and Neutrophil Dysfunction in Chronic Kidney Disease</article-title>,&#x0201d; <source>Scientific Reports</source>
<volume>6</volume> (<year>2016</year>): <elocation-id>34534</elocation-id>, <pub-id pub-id-type="doi">10.1038/srep34534</pub-id>.<pub-id pub-id-type="pmid">27698480</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="apha70057-cit-0035">
<string-name>
<given-names>M. I.</given-names>
<surname>Muniz&#x02010;Junqueira</surname>
</string-name>, <string-name>
<given-names>C. B.</given-names>
<surname>Lopes</surname>
</string-name>, <string-name>
<given-names>C. A.</given-names>
<surname>Magalh&#x000e3;es</surname>
</string-name>, <string-name>
<given-names>C. C.</given-names>
<surname>Schleicher</surname>
</string-name>, and <string-name>
<given-names>J. P.</given-names>
<surname>Veiga</surname>
</string-name>, &#x0201c;<article-title>Acute and Chronic Influence of Hemodialysis According to the Membrane Used on Phagocytic Function of Neutrophils and Monocytes and Pro&#x02010;Inflammatory Cytokines Production in Chronic Renal Failure Patients</article-title>,&#x0201d; <source>Life Sciences</source>
<volume>77</volume> (<year>2005</year>): <fpage>3141</fpage>&#x02013;<lpage>3155</lpage>, <pub-id pub-id-type="doi">10.1016/j.lfs.2005.03.034</pub-id>.<pub-id pub-id-type="pmid">16005905</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="apha70057-cit-0036">
<string-name>
<given-names>S.</given-names>
<surname>Mahajan</surname>
</string-name>, <string-name>
<given-names>O. P.</given-names>
<surname>Kalra</surname>
</string-name>, <string-name>
<given-names>K. T.</given-names>
<surname>Asit</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Ahuja</surname>
</string-name>, and <string-name>
<given-names>V.</given-names>
<surname>Kalra</surname>
</string-name>, &#x0201c;<article-title>Phagocytic Polymorphonuclear Function in Patients With Progressive Uremia and the Effect of Acute Hemodialysis</article-title>,&#x0201d; <source>Renal Failure</source>
<volume>27</volume> (<year>2005</year>): <fpage>357</fpage>&#x02013;<lpage>360</lpage>, <pub-id pub-id-type="doi">10.1081/JDI-200065223</pub-id>.<pub-id pub-id-type="pmid">16060119</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="apha70057-cit-0037">
<string-name>
<given-names>C. J.</given-names>
<surname>Porter</surname>
</string-name>, <string-name>
<given-names>R. P.</given-names>
<surname>Burden</surname>
</string-name>, <string-name>
<given-names>A. G.</given-names>
<surname>Morgan</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Daniels</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Fletcher</surname>
</string-name>, &#x0201c;<article-title>Impaired Polymorphonuclear Neutrophil Function in End&#x02010;Stage Renal Failure and Its Correction by Continuous Ambulatory Peritoneal Dialysis</article-title>,&#x0201d; <source>Nephron</source>
<volume>71</volume> (<year>1995</year>): <fpage>133</fpage>&#x02013;<lpage>137</lpage>, <pub-id pub-id-type="doi">10.1159/000188700</pub-id>.<pub-id pub-id-type="pmid">8569942</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="apha70057-cit-0038">
<string-name>
<given-names>J. M.</given-names>
<surname>Alexiewicz</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Smogorzewski</surname>
</string-name>, <string-name>
<given-names>G. Z.</given-names>
<surname>Fadda</surname>
</string-name>, and <string-name>
<given-names>S. G.</given-names>
<surname>Massry</surname>
</string-name>, &#x0201c;<article-title>Impaired Phagocytosis in Dialysis Patients: Studies on Mechanisms</article-title>,&#x0201d; <source>American Journal of Nephrology</source>
<volume>11</volume> (<year>1991</year>): <fpage>102</fpage>&#x02013;<lpage>111</lpage>, <pub-id pub-id-type="doi">10.1159/000168284</pub-id>.<pub-id pub-id-type="pmid">1951470</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="apha70057-cit-0039">
<string-name>
<given-names>J. M.</given-names>
<surname>Alexiewicz</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Smogorzewski</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Klin</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Akmal</surname>
</string-name>, and <string-name>
<given-names>S. G.</given-names>
<surname>Massry</surname>
</string-name>, &#x0201c;<article-title>Effect of Treatment of Hemodialysis Patients With Nifedipine on Metabolism and Function of Polymorphonuclear Leukocytes</article-title>,&#x0201d; <source>American Journal of Kidney Diseases</source>
<volume>25</volume> (<year>1995</year>): <fpage>440</fpage>&#x02013;<lpage>444</lpage>, <pub-id pub-id-type="doi">10.1016/0272-6386(95)90106-x</pub-id>.<pub-id pub-id-type="pmid">7872322</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="apha70057-cit-0040">
<string-name>
<given-names>G.</given-names>
<surname>Banche</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Allizond</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Giacchino</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Effect of Dialysis Membrane Biocompatibility on Polymorphonuclear Granulocyte Activity in Dialysis Patients</article-title>,&#x0201d; <source>Nephrology, Dialysis, Transplantation</source>
<volume>21</volume> (<year>2006</year>): <fpage>3532</fpage>&#x02013;<lpage>3538</lpage>, <pub-id pub-id-type="doi">10.1093/ndt/gfl415</pub-id>.</mixed-citation></ref><ref id="apha70057-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="apha70057-cit-0041">
<string-name>
<given-names>A. M.</given-names>
<surname>Cuffini</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Tullio</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Giacchino</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Impact of Co&#x02010;Amoxiclav on Polymorphonuclear Granulocytes From Chronic Hemodialysis Patients</article-title>,&#x0201d; <source>American Journal of Kidney Diseases</source>
<volume>37</volume> (<year>2001</year>): <fpage>1253</fpage>&#x02013;<lpage>1259</lpage>, <pub-id pub-id-type="doi">10.1053/ajkd.2001.24530</pub-id>.<pub-id pub-id-type="pmid">11382696</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="apha70057-cit-0042">
<string-name>
<given-names>E. M.</given-names>
<surname>Pappas</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Mpournaka</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Katopodis</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>The Effect of Dialysis Modality and Membrane Performance on Native Immunity in Dialysis Patients</article-title>,&#x0201d; <source>Pril (Makedon Akad Nauk Umet Odd Med Nauki)</source>
<volume>40</volume> (<year>2019</year>): <fpage>25</fpage>&#x02013;<lpage>32</lpage>, <pub-id pub-id-type="doi">10.2478/prilozi-2019-0011</pub-id>.<pub-id pub-id-type="pmid">31605588</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="apha70057-cit-0043">
<string-name>
<given-names>K.</given-names>
<surname>Anding</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Gross</surname>
</string-name>, <string-name>
<given-names>J. M.</given-names>
<surname>Rost</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Allgaier</surname>
</string-name>, and <string-name>
<given-names>E.</given-names>
<surname>Jacobs</surname>
</string-name>, &#x0201c;<article-title>The Influence of Uraemia and Haemodialysis on Neutrophil Phagocytosis and Antimicrobial Killing</article-title>,&#x0201d; <source>Nephrology, Dialysis, Transplantation</source>
<volume>18</volume> (<year>2003</year>): <fpage>2067</fpage>&#x02013;<lpage>2073</lpage>, <pub-id pub-id-type="doi">10.1093/ndt/gfg330</pub-id>.</mixed-citation></ref><ref id="apha70057-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="apha70057-cit-0044">
<string-name>
<given-names>D.</given-names>
<surname>Scalas</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Banche</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Merlino</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Role of Caspofungin in Restoring the Impaired Phagocyte&#x02010;Dependent Innate Immunity Towards <styled-content style="fixed-case" toggle="no">
<italic toggle="no">Candida albicans</italic>
</styled-content> in Chronic Haemodialysis Patients</article-title>,&#x0201d; <source>International Journal of Antimicrobial Agents</source>
<volume>39</volume> (<year>2012</year>): <fpage>73</fpage>&#x02013;<lpage>76</lpage>, <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2011.09.015</pub-id>.<pub-id pub-id-type="pmid">22055531</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="apha70057-cit-0045">
<string-name>
<given-names>V.</given-names>
<surname>Tullio</surname>
</string-name>, <string-name>
<given-names>A. M.</given-names>
<surname>Cuffini</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Giacchino</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Combined Action of Fluconazole and PMNs From Uremic Patients in Clearing Intracellular <styled-content style="fixed-case" toggle="no">
<italic toggle="no">Candida albicans</italic>
</styled-content>
</article-title>,&#x0201d; <source>Journal of Chemotherapy</source>
<volume>15</volume> (<year>2003</year>): <fpage>301</fpage>&#x02013;<lpage>303</lpage>, <pub-id pub-id-type="doi">10.1179/joc.2003.15.3.301</pub-id>.<pub-id pub-id-type="pmid">12868562</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="apha70057-cit-0046">
<string-name>
<given-names>S.</given-names>
<surname>Schauer</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Stein</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>S&#x000fc;ss</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Falkenhagen</surname>
</string-name>, and <string-name>
<given-names>W.</given-names>
<surname>Linss</surname>
</string-name>, &#x0201c;<article-title>Phagocytosis Activity of Polymorphonuclear Cells of Normal Persons and Dialysis Patients Is Influenced by Different Dialysis Membranes</article-title>,&#x0201d; <source>Nephrology, Dialysis, Transplantation</source>
<volume>6</volume>, no. <issue>Suppl 3</issue> (<year>1991</year>): <fpage>35</fpage>&#x02013;<lpage>40</lpage>.</mixed-citation></ref><ref id="apha70057-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="apha70057-cit-0047">
<string-name>
<given-names>P.</given-names>
<surname>Bartnicki</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Majewska</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Kowalczyk</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Baj</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Banach</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Rysz</surname>
</string-name>, &#x0201c;<article-title>Impact of Anemia Treatment With Methoxy Polyethylene Glycol&#x02010;Epoetin Beta on Polymorphonuclear Cells Apoptosis in Predialysis Patients With Chronic Kidney Disease</article-title>,&#x0201d; <source>Pharmacological Reports</source>
<volume>67</volume> (<year>2015</year>): <fpage>842</fpage>&#x02013;<lpage>845</lpage>, <pub-id pub-id-type="doi">10.1016/j.pharep.2015.01.014</pub-id>.<pub-id pub-id-type="pmid">26398374</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="apha70057-cit-0048">
<string-name>
<given-names>B. L.</given-names>
<surname>Jaber</surname>
</string-name>, <string-name>
<given-names>M. C.</given-names>
<surname>Perianayagam</surname>
</string-name>, <string-name>
<given-names>V. S.</given-names>
<surname>Balakrishnan</surname>
</string-name>, <string-name>
<given-names>A. J.</given-names>
<surname>King</surname>
</string-name>, and <string-name>
<given-names>B. J.</given-names>
<surname>Pereira</surname>
</string-name>, &#x0201c;<article-title>Mechanisms of Neutrophil Apoptosis in Uremia and Relevance of the Fas (APO&#x02010;1, CD95)/Fas Ligand System</article-title>,&#x0201d; <source>Journal of Leukocyte Biology</source>
<volume>69</volume> (<year>2001</year>): <fpage>1006</fpage>&#x02013;<lpage>1012</lpage>.<pub-id pub-id-type="pmid">11404388</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="apha70057-cit-0049">
<string-name>
<given-names>N.</given-names>
<surname>Zahran</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Sayed</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>William</surname>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>Mahmoud</surname>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>Sabry</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Rafaat</surname>
</string-name>, &#x0201c;<article-title>Neutrophil Apoptosis: Impact of Granulocyte Macrophage Colony Stimulating Factor on Cell Survival and Viability in Chronic Kidney Disease and Hemodialysis Patients</article-title>,&#x0201d; <source>Archives of Medical Science</source>
<volume>9</volume> (<year>2013</year>): <fpage>984</fpage>&#x02013;<lpage>989</lpage>, <pub-id pub-id-type="doi">10.5114/aoms.2013.39789</pub-id>.<pub-id pub-id-type="pmid">24482640</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="apha70057-cit-0050">
<string-name>
<given-names>N.</given-names>
<surname>Nahar</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Shah</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Siu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Dialysis Membrane&#x02010;Induced Neutrophil Apoptosis Is Mediated Through Free Radicals</article-title>,&#x0201d; <source>Clinical Nephrology</source>
<volume>56</volume> (<year>2001</year>): <fpage>52</fpage>&#x02013;<lpage>59</lpage>.<pub-id pub-id-type="pmid">11499659</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="apha70057-cit-0051">
<string-name>
<given-names>G.</given-names>
<surname>Cohen</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Raupachova</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Wimmer</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Deicher</surname>
</string-name>, and <string-name>
<given-names>W. H.</given-names>
<surname>H&#x000f6;rl</surname>
</string-name>, &#x0201c;<article-title>The Uraemic Retention Solute Para&#x02010;Hydroxy&#x02010;Hippuric Acid Attenuates Apoptosis of Polymorphonuclear Leukocytes From Healthy Subjects but Not From Haemodialysis Patients</article-title>,&#x0201d; <source>Nephrology, Dialysis, Transplantation</source>
<volume>23</volume> (<year>2008</year>): <fpage>2512</fpage>&#x02013;<lpage>2519</lpage>, <pub-id pub-id-type="doi">10.1093/ndt/gfn098</pub-id>.</mixed-citation></ref><ref id="apha70057-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="apha70057-cit-0052">
<string-name>
<given-names>L.</given-names>
<surname>Dou</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Brunet</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Dignat&#x02010;George</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Sampol</surname>
</string-name>, and <string-name>
<given-names>Y.</given-names>
<surname>Berland</surname>
</string-name>, &#x0201c;<article-title>Effect of Uremia and Hemodialysis on Soluble L&#x02010;Selectin and Leukocyte Surface CD11b and L&#x02010;Selectin</article-title>,&#x0201d; <source>American Journal of Kidney Diseases</source>
<volume>31</volume> (<year>1998</year>): <fpage>67</fpage>&#x02013;<lpage>73</lpage>, <pub-id pub-id-type="doi">10.1053/ajkd.1998.v31.pm9428454</pub-id>.<pub-id pub-id-type="pmid">9428454</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="apha70057-cit-0053">
<string-name>
<given-names>J.</given-names>
<surname>Olsson</surname>
</string-name>, <string-name>
<given-names>T. A.</given-names>
<surname>Jacobson</surname>
</string-name>, <string-name>
<given-names>J. M.</given-names>
<surname>Paulsson</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Expression of Neutrophil SOD2 Is Reduced After Lipopolysaccharide Stimulation: A Potential Cause of Neutrophil Dysfunction in Chronic Kidney Disease</article-title>,&#x0201d; <source>Nephrology, Dialysis, Transplantation</source>
<volume>26</volume> (<year>2011</year>): <fpage>2195</fpage>&#x02013;<lpage>2201</lpage>, <pub-id pub-id-type="doi">10.1093/ndt/gfq673</pub-id>.</mixed-citation></ref><ref id="apha70057-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="apha70057-cit-0054">
<string-name>
<given-names>C.</given-names>
<surname>Wallquist</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Mansouri</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Norrback</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Associations of Fibroblast Growth Factor 23 With Markers of Inflammation and Leukocyte Transmigration in Chronic Kidney Disease</article-title>,&#x0201d; <source>Nephron</source>
<volume>138</volume> (<year>2018</year>): <fpage>287</fpage>&#x02013;<lpage>295</lpage>, <pub-id pub-id-type="doi">10.1159/000485472</pub-id>.<pub-id pub-id-type="pmid">29301137</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="apha70057-cit-0055">
<string-name>
<given-names>D. M.</given-names>
<surname>Eldewi</surname>
</string-name>, <string-name>
<given-names>A. M.</given-names>
<surname>Alhabibi</surname>
</string-name>, <string-name>
<given-names>H. M. E.</given-names>
<surname>El Sayek</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Expression Levels of Complement Regulatory Proteins (CD35, CD55 and CD59) on Peripheral Blood Cells of Patients With Chronic Kidney Disease</article-title>,&#x0201d; <source>International Journal of General Medicine</source>
<volume>12</volume> (<year>2019</year>): <fpage>343</fpage>&#x02013;<lpage>351</lpage>, <pub-id pub-id-type="doi">10.2147/ijgm.S216989</pub-id>.<pub-id pub-id-type="pmid">31571973</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="apha70057-cit-0056">
<string-name>
<given-names>Z.</given-names>
<surname>Aljadi</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Mansouri</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Nopp</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Activation of Basophils Is a New and Sensitive Marker of Biocompatibility in Hemodialysis</article-title>,&#x0201d; <source>Artificial Organs</source>
<volume>38</volume> (<year>2014</year>): <fpage>945</fpage>&#x02013;<lpage>953</lpage>, <pub-id pub-id-type="doi">10.1111/aor.12297</pub-id>.<pub-id pub-id-type="pmid">24712758</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="apha70057-cit-0057">
<string-name>
<given-names>R.</given-names>
<surname>Pereira</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Costa</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Gon&#x000e7;alves</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Neutrophil and Monocyte Activation in Chronic Kidney Disease Patients Under Hemodialysis and Its Relationship With Resistance to Recombinant Human Erythropoietin and to the Hemodialysis Procedure</article-title>,&#x0201d; <source>Hemodialysis International</source>
<volume>14</volume> (<year>2010</year>): <fpage>295</fpage>&#x02013;<lpage>301</lpage>, <pub-id pub-id-type="doi">10.1111/j.1542-4758.2010.00450.x</pub-id>.<pub-id pub-id-type="pmid">20649681</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="apha70057-cit-0058">
<string-name>
<given-names>E.</given-names>
<surname>Costa</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Rocha</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Rocha&#x02010;Pereira</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Neutrophil Activation and Resistance to Recombinant Human Erythropoietin Therapy in Hemodialysis Patients</article-title>,&#x0201d; <source>American Journal of Kidney Diseases</source>
<volume>28</volume>, no. <issue>6</issue> (<year>2008</year>): <fpage>935</fpage>&#x02013;<lpage>940</lpage>, <pub-id pub-id-type="doi">10.1159/000142147</pub-id>.</mixed-citation></ref><ref id="apha70057-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="apha70057-cit-0059">
<string-name>
<given-names>E.</given-names>
<surname>Khatib&#x02010;Massalha</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Michelis</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Trabelcy</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Free Circulating Active Elastase Contributes to Chronic Inflammation in Patients on Hemodialysis</article-title>,&#x0201d; <source>American Journal of Physiology. Renal Physiology</source>
<volume>314</volume> (<year>2018</year>): <fpage>F203</fpage>&#x02013;<lpage>f209</lpage>, <pub-id pub-id-type="doi">10.1152/ajprenal.00070.2017</pub-id>.<pub-id pub-id-type="pmid">29046295</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="apha70057-cit-0060">
<string-name>
<given-names>C.</given-names>
<surname>Capeillere&#x02010;Blandin</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Gausson</surname>
</string-name>, <string-name>
<given-names>A. T.</given-names>
<surname>Nguyen</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Descamps&#x02010;Latscha</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Drueke</surname>
</string-name>, and <string-name>
<given-names>V.</given-names>
<surname>Witko&#x02010;Sarsat</surname>
</string-name>, &#x0201c;<article-title>Respective Role of Uraemic Toxins and Myeloperoxidase in the Uraemic State</article-title>,&#x0201d; <source>Nephrology, Dialysis, Transplantation</source>
<volume>21</volume> (<year>2006</year>): <fpage>1555</fpage>&#x02013;<lpage>1563</lpage>, <pub-id pub-id-type="doi">10.1093/ndt/gfl007</pub-id>.</mixed-citation></ref><ref id="apha70057-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="apha70057-cit-0061">
<string-name>
<given-names>M. S.</given-names>
<surname>Tsai</surname>
</string-name>, <string-name>
<given-names>H. M.</given-names>
<surname>Shaw</surname>
</string-name>, <string-name>
<given-names>Y. J.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>M. T.</given-names>
<surname>Lin</surname>
</string-name>, <string-name>
<given-names>W. T.</given-names>
<surname>Lee</surname>
</string-name>, and <string-name>
<given-names>K. S.</given-names>
<surname>Chan</surname>
</string-name>, &#x0201c;<article-title>Myeloperoxidase in Chronic Kidney Disease: Role of Visceral Fat</article-title>,&#x0201d; <source>Nephrology</source>
<volume>19</volume> (<year>2014</year>): <fpage>136</fpage>&#x02013;<lpage>142</lpage>, <pub-id pub-id-type="doi">10.1111/nep.12187</pub-id>.<pub-id pub-id-type="pmid">24330098</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0062"><label>62</label><mixed-citation publication-type="journal" id="apha70057-cit-0062">
<string-name>
<given-names>R.</given-names>
<surname>Deicher</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Exner</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Cohen</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Haag&#x02010;Weber</surname>
</string-name>, and <string-name>
<given-names>W. H.</given-names>
<surname>H&#x000f6;rl</surname>
</string-name>, &#x0201c;<article-title>Neutrophil Beta(2)&#x02010;Microglobulin and Lactoferrin Content in Renal Failure Patients</article-title>,&#x0201d; <source>American Journal of Kidney Diseases</source>
<volume>35</volume> (<year>2000</year>): <fpage>1117</fpage>&#x02013;<lpage>1126</lpage>, <pub-id pub-id-type="doi">10.1016/s0272-6386(00)70049-7</pub-id>.<pub-id pub-id-type="pmid">10845826</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0063"><label>63</label><mixed-citation publication-type="journal" id="apha70057-cit-0063">
<string-name>
<given-names>J. C.</given-names>
<surname>Jeong</surname>
</string-name>, <string-name>
<given-names>J. E.</given-names>
<surname>Kim</surname>
</string-name>, <string-name>
<given-names>J. Y.</given-names>
<surname>Gu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Significance of the DNA&#x02010;Histone Complex Level as a Predictor of Major Adverse Cardiovascular Events in Hemodialysis Patients: The Effect of Uremic Toxin on DNA&#x02010;Histone Complex Formation</article-title>,&#x0201d; <source>Blood Purification</source>
<volume>41</volume> (<year>2016</year>): <fpage>64</fpage>&#x02013;<lpage>71</lpage>, <pub-id pub-id-type="doi">10.1159/000440974</pub-id>.<pub-id pub-id-type="pmid">26517236</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0064"><label>64</label><mixed-citation publication-type="journal" id="apha70057-cit-0064">
<string-name>
<given-names>J. K.</given-names>
<surname>Kim</surname>
</string-name>, <string-name>
<given-names>M. J.</given-names>
<surname>Park</surname>
</string-name>, <string-name>
<given-names>H. W.</given-names>
<surname>Lee</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>The Relationship Between Autophagy, Increased Neutrophil Extracellular Traps Formation and Endothelial Dysfunction in Chronic Kidney Disease</article-title>,&#x0201d; <source>Clinical Immunology</source>
<volume>197</volume> (<year>2018</year>): <fpage>189</fpage>&#x02013;<lpage>197</lpage>, <pub-id pub-id-type="doi">10.1016/j.clim.2018.10.003</pub-id>.<pub-id pub-id-type="pmid">30296592</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0065"><label>65</label><mixed-citation publication-type="journal" id="apha70057-cit-0065">
<string-name>
<given-names>C.</given-names>
<surname>Vega&#x02010;Roman</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Leal&#x02010;Cortes</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Portilla&#x02010;de Buen</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Impact of Transplantation on Neutrophil Extracellular Trap Formation in Patients With End&#x02010;Stage Renal Disease: A Single&#x02010;Center, Prospective Cohort Study</article-title>,&#x0201d; <source>Medicine</source>
<volume>100</volume> (<year>2021</year>): <elocation-id>e26595</elocation-id>, <pub-id pub-id-type="doi">10.1097/md.0000000000026595</pub-id>.<pub-id pub-id-type="pmid">34232209</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0066"><label>66</label><mixed-citation publication-type="journal" id="apha70057-cit-0066">
<string-name>
<given-names>S.</given-names>
<surname>Grazioli</surname>
</string-name> and <string-name>
<given-names>J.</given-names>
<surname>Pugin</surname>
</string-name>, &#x0201c;<article-title>Mitochondrial Damage&#x02010;Associated Molecular Patterns: From Inflammatory Signaling to Human Diseases</article-title>,&#x0201d; <source>Frontiers in Immunology</source>
<volume>9</volume> (<year>2018</year>): <elocation-id>832</elocation-id>, <pub-id pub-id-type="doi">10.3389/fimmu.2018.00832</pub-id>.<pub-id pub-id-type="pmid">29780380</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0067"><label>67</label><mixed-citation publication-type="journal" id="apha70057-cit-0067">
<string-name>
<given-names>M. G.</given-names>
<surname>Betjes</surname>
</string-name>, &#x0201c;<article-title>Immune Cell Dysfunction and Inflammation in End&#x02010;Stage Renal Disease</article-title>,&#x0201d; <source>Nature Reviews Nephrology</source>
<volume>9</volume> (<year>2013</year>): <fpage>255</fpage>&#x02013;<lpage>265</lpage>, <pub-id pub-id-type="doi">10.1038/nrneph.2013.44</pub-id>.<pub-id pub-id-type="pmid">23507826</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0068"><label>68</label><mixed-citation publication-type="journal" id="apha70057-cit-0068">
<string-name>
<given-names>T.</given-names>
<surname>Ebert</surname>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>Neytchev</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Witasp</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Kublickiene</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Stenvinkel</surname>
</string-name>, and <string-name>
<given-names>P. G.</given-names>
<surname>Shiels</surname>
</string-name>, &#x0201c;<article-title>Inflammation and Oxidative Stress in Chronic Kidney Disease and Dialysis Patients</article-title>,&#x0201d; <source>Antioxidants &#x00026; Redox Signaling</source>
<volume>35</volume> (<year>2021</year>): <fpage>1426</fpage>&#x02013;<lpage>1448</lpage>, <pub-id pub-id-type="doi">10.1089/ars.2020.8184</pub-id>.<pub-id pub-id-type="pmid">34006115</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0069"><label>69</label><mixed-citation publication-type="journal" id="apha70057-cit-0069">
<string-name>
<given-names>R.</given-names>
<surname>Vanholder</surname>
</string-name> and <string-name>
<given-names>S.</given-names>
<surname>Ringoir</surname>
</string-name>, &#x0201c;<article-title>Polymorphonuclear Cell Function and Infection in Dialysis</article-title>,&#x0201d; <source>Kidney International. Supplement</source>
<volume>38</volume> (<year>1992</year>): <fpage>S91</fpage>&#x02013;<lpage>S95</lpage>.<pub-id pub-id-type="pmid">1405386</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0070"><label>70</label><mixed-citation publication-type="journal" id="apha70057-cit-0070">
<string-name>
<given-names>G.</given-names>
<surname>Cohen</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Haag&#x02010;Weber</surname>
</string-name>, and <string-name>
<given-names>W. H.</given-names>
<surname>H&#x000f6;rl</surname>
</string-name>, &#x0201c;<article-title>Immune Dysfunction in Uremia</article-title>,&#x0201d; <source>Kidney International. Supplement</source>
<volume>62</volume> (<year>1997</year>): <fpage>S79</fpage>&#x02013;<lpage>S82</lpage>.<pub-id pub-id-type="pmid">9350688</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0071"><label>71</label><mixed-citation publication-type="journal" id="apha70057-cit-0071">
<string-name>
<given-names>E.</given-names>
<surname>Papachristoforou</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Lambadiari</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Maratou</surname>
</string-name>, and <string-name>
<given-names>K.</given-names>
<surname>Makrilakis</surname>
</string-name>, &#x0201c;<article-title>Association of Glycemic Indices (Hyperglycemia, Glucose Variability, and Hypoglycemia) With Oxidative Stress and Diabetic Complications</article-title>,&#x0201d; <source>Journal of Diabetes Research</source>
<volume>2020</volume> (<year>2020</year>): <elocation-id>7489795</elocation-id>, <pub-id pub-id-type="doi">10.1155/2020/7489795</pub-id>.<pub-id pub-id-type="pmid">33123598</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0072"><label>72</label><mixed-citation publication-type="journal" id="apha70057-cit-0072">
<string-name>
<given-names>S. L.</given-names>
<surname>Wong</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Demers</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Martinod</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Diabetes Primes Neutrophils to Undergo NETosis, Which Impairs Wound Healing</article-title>,&#x0201d; <source>Nature Medicine</source>
<volume>21</volume> (<year>2015</year>): <fpage>815</fpage>&#x02013;<lpage>819</lpage>, <pub-id pub-id-type="doi">10.1038/nm.3887</pub-id>.</mixed-citation></ref><ref id="apha70057-bib-0073"><label>73</label><mixed-citation publication-type="journal" id="apha70057-cit-0073">
<string-name>
<given-names>R.</given-names>
<surname>Vanholder</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Van Biesen</surname>
</string-name>, and <string-name>
<given-names>S.</given-names>
<surname>Ringoir</surname>
</string-name>, &#x0201c;<article-title>Contributing Factors to the Inhibition of Phagocytosis in Hemodialyzed Patients</article-title>,&#x0201d; <source>Kidney International</source>
<volume>44</volume> (<year>1993</year>): <fpage>208</fpage>&#x02013;<lpage>214</lpage>, <pub-id pub-id-type="doi">10.1038/ki.1993.232</pub-id>.<pub-id pub-id-type="pmid">8355462</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0074"><label>74</label><mixed-citation publication-type="journal" id="apha70057-cit-0074">
<string-name>
<given-names>L. P.</given-names>
<surname>Roma</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Deponte</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Riemer</surname>
</string-name>, and <string-name>
<given-names>B.</given-names>
<surname>Morgan</surname>
</string-name>, &#x0201c;<article-title>Mechanisms and Applications of Redox&#x02010;Sensitive Green Fluorescent Protein&#x02010;Based Hydrogen Peroxide Probes</article-title>,&#x0201d; <source>Antioxidants &#x00026; Redox Signaling</source>
<volume>29</volume> (<year>2018</year>): <fpage>552</fpage>&#x02013;<lpage>568</lpage>, <pub-id pub-id-type="doi">10.1089/ars.2017.7449</pub-id>.<pub-id pub-id-type="pmid">29160083</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0075"><label>75</label><mixed-citation publication-type="journal" id="apha70057-cit-0075">
<string-name>
<given-names>M.</given-names>
<surname>Schwarzl&#x000e4;nder</surname>
</string-name>, <string-name>
<given-names>T. P.</given-names>
<surname>Dick</surname>
</string-name>, <string-name>
<given-names>A. J.</given-names>
<surname>Meyer</surname>
</string-name>, and <string-name>
<given-names>B.</given-names>
<surname>Morgan</surname>
</string-name>, &#x0201c;<article-title>Dissecting Redox Biology Using Fluorescent Protein Sensors</article-title>,&#x0201d; <source>Antioxidants &#x00026; Redox Signaling</source>
<volume>24</volume> (<year>2016</year>): <fpage>680</fpage>&#x02013;<lpage>712</lpage>, <pub-id pub-id-type="doi">10.1089/ars.2015.6266</pub-id>.<pub-id pub-id-type="pmid">25867539</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0076"><label>76</label><mixed-citation publication-type="journal" id="apha70057-cit-0076">
<string-name>
<given-names>L. P.</given-names>
<surname>Roma</surname>
</string-name> and <string-name>
<given-names>J. C.</given-names>
<surname>Jonas</surname>
</string-name>, &#x0201c;<article-title>Nutrient Metabolism, Subcellular Redox State, and Oxidative Stress in Pancreatic Islets and &#x003b2;&#x02010;Cells</article-title>,&#x0201d; <source>Journal of Molecular Biology</source>
<volume>432</volume> (<year>2020</year>): <fpage>1461</fpage>&#x02013;<lpage>1493</lpage>, <pub-id pub-id-type="doi">10.1016/j.jmb.2019.10.012</pub-id>.<pub-id pub-id-type="pmid">31634466</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0077"><label>77</label><mixed-citation publication-type="journal" id="apha70057-cit-0077">
<string-name>
<given-names>H.</given-names>
<surname>Sies</surname>
</string-name>, <string-name>
<given-names>V. V.</given-names>
<surname>Belousov</surname>
</string-name>, <string-name>
<given-names>N. S.</given-names>
<surname>Chandel</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Defining Roles of Specific Reactive Oxygen Species (ROS) in Cell Biology and Physiology</article-title>,&#x0201d; <source>Nature Reviews. Molecular Cell Biology</source>
<volume>23</volume> (<year>2022</year>): <fpage>499</fpage>&#x02013;<lpage>515</lpage>, <pub-id pub-id-type="doi">10.1038/s41580-022-00456-z</pub-id>.<pub-id pub-id-type="pmid">35190722</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0078"><label>78</label><mixed-citation publication-type="journal" id="apha70057-cit-0078">
<string-name>
<given-names>C.</given-names>
<surname>Silvestre&#x02010;Roig</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Hidalgo</surname>
</string-name>, and <string-name>
<given-names>O.</given-names>
<surname>Soehnlein</surname>
</string-name>, &#x0201c;<article-title>Neutrophil Heterogeneity: Implications for Homeostasis and Pathogenesis</article-title>,&#x0201d; <source>Blood</source>
<volume>127</volume> (<year>2016</year>): <fpage>2173</fpage>&#x02013;<lpage>2181</lpage>, <pub-id pub-id-type="doi">10.1182/blood-2016-01-688887</pub-id>.<pub-id pub-id-type="pmid">27002116</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0079"><label>79</label><mixed-citation publication-type="journal" id="apha70057-cit-0079">
<string-name>
<given-names>M.</given-names>
<surname>Palomino&#x02010;Segura</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Sicilia</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Ballesteros</surname>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Hidalgo</surname>
</string-name>, &#x0201c;<article-title>Strategies of Neutrophil Diversification</article-title>,&#x0201d; <source>Nature Immunology</source>
<volume>24</volume> (<year>2023</year>): <fpage>575</fpage>&#x02013;<lpage>584</lpage>, <pub-id pub-id-type="doi">10.1038/s41590-023-01452-x</pub-id>.<pub-id pub-id-type="pmid">36959290</pub-id>
</mixed-citation></ref><ref id="apha70057-bib-0080"><label>80</label><mixed-citation publication-type="journal" id="apha70057-cit-0080">
<string-name>
<given-names>C.</given-names>
<surname>Baaten</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Vondenhoff</surname>
</string-name>, and <string-name>
<given-names>H.</given-names>
<surname>Noels</surname>
</string-name>, &#x0201c;<article-title>Endothelial Cell Dysfunction and Increased Cardiovascular Risk in Patients With Chronic Kidney Disease</article-title>,&#x0201d; <source>Circulation Research</source>
<volume>132</volume> (<year>2023</year>): <fpage>970</fpage>&#x02013;<lpage>992</lpage>, <pub-id pub-id-type="doi">10.1161/circresaha.123.321752</pub-id>.<pub-id pub-id-type="pmid">37053275</pub-id>
</mixed-citation></ref></ref-list></back></article>